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ABSTRACT 
 
Tara Lynn Oman 
 
REGULATION OF OUTER SURFACE LIPOPROTEIN A IN THE LYME DISEASE 
SPIROCHETE BORRELIA BURGDORFERI 
 
Borrelia burgdorferi, a bacterium which causes Lyme disease, is maintained in nature 
through a cycle involving two distinct hosts: a tick vector and a mammalian host. To 
adapt to these two diverse environments, B. burgdorferi undergoes dramatic alterations 
in its surface lipoprotein. Two essential lipoproteins, outer surface protein A (OspA) and 
outer surface protein C (OspC), are reciprocally regulated throughout the B. burgdorferi 
lifecycle. Very little is known about the regulation of OspA. These studies elucidate the 
regulatory mechanisms controlling the expression of OspA. Various truncations of the 
ospA promoter were created and then studied in our novel in vitro model of ospA 
repression or grown within the host-adapted model. A T-Rich region of the ospA 
promoter was determined to be a cis-element essential for both the full expression and 
full repression of ospA. 
 
X. Frank Yang, Ph.D.- Chair 
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CHAPTER ONE: INTRODUCTION 
 
History of Lyme disease 
Lyme disease is the most common arthropod-borne disease in the United States. In 
1975, in Lyme, Connecticut, an unusual number of children presented symptoms of 
Juvenile Rheumatoid Arthritis (Steere et al., 1977). Although the definitive cause had not 
been confirmed, an infectious agent was suggested to be responsible for the arthritis 
displayed in the children. It was suspected that the unidentified infectious agent was 
being spread via an arthropod vector given that the patients lived near wooded areas 
and the highest frequency of outbreaks occurred in the summer (Steere et al., 1979; 
Steere et al., 1977). Around this same period, outbreaks of spotted fever spread by 
Rickettsia-infected ticks were occurring on Long Island, New York. In 1984, scientist 
Willy Burgdorfer was collecting tick samples in attempts to isolate a virulent strain of 
Rickettsia rickettsii. Incidentally, during this endeavor, Willy Burgdorfer discovered the 
spirochete Borrelia burgdorferi. It was suspected that this newly discovered bacterium 
was the causative agent of the arthritis cases in Lyme Connecticut (Burgdorfer, 2006; 
Burgdorfer et al., 1985). To confirm this notion, sera were taken from the patients in 
Lyme, Connecticut that were misdiagnosed with Juvenile Rheumatoid Arthritis and the 
presence of B. burgdorferi was confirmed.  
 
Epidemiology of Lyme disease 
B. burgdorferi is the primary causative agent of Lyme disease (Burgdorfer et al., 1985). 
Twelve of the thirty-seven known Borrelia species are capable of causing Lyme disease 
(Hengge et al., 2003). Lyme disease is an emerging infectious disease throughout 
Europe, Asia, South America, and Canada as well as the United States. According to the 
Center for Disease Control and Prevention (CDC), Lyme disease is the most common 
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vector-borne illness in the United States (2011). The number of reported Lyme disease 
cases has increased over the past 14 years. In 1996, there were 17,730 confirmed 
cases of Lyme disease while in 2010 there were 22,572 confirmed cases and 597 
probable cases of Lyme disease in the United States as reported by the CDC (Figure 1).  
 
Lyme disease is endemic in several areas of the United States, but is concentrated in 
the Northeastern and the upper Northeastern states (Figure 2). According to the CDC, 
94% of the total Lyme disease cases were reported from just the following 12 states: 
Connecticut, Delaware, Maine, Maryland, Massachusetts, Minnesota, New Jersey, New 
Hampshire, New York, Pennsylvania, Virginia and Wisconsin (2010). Lyme disease is 
most prevalent in these states because they have a wooded, grassy environment which 
supports B. burgdorferi’s vector, the deer tick Ixodes scapularis, as well as the 
mammalian hosts required for the complete B. burgdorferi natural lifecycle. 
 
Natural Lifecycle of B. burgdorferi  
In nature, B. burgdorferi is maintained via an enzootic cycle being transmitted between a 
tick vector, the Ixodes tick, and a mammalian host, usually small animals like the white-
footed mouse, rabbit and some birds (Anderson, 1998). In the United States, I. 
scapularis is the main arthropod vector in the upper Midwestern and the Northeastern 
parts of the country while the Western blacklegged tick, Ixodes pacificus, is the main 
arthropod vector in the western part of the country. The tick’s lifespan is only two years. 
During their lifespan, the tick matures from an egg and then transforms into larval, 
nymph, and adult stages (Figure 3). The tick takes three blood meals throughout its 
entire life- once during each of its last three stages of development.  
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The adult female ticks lay eggs during the spring time, and then the eggs hatch during 
the summer into larvae. Upon hatching, the naïve larvae acquire B. burgdorferi when the 
tick larva takes a blood meal from a Borrelia-infected small mammal, usually a white-
footed mouse. Because B. burgdorferi cannot be transmitted transovarially, infected ticks 
cannot pass the bacterium to its offspring and therefore the offspring must acquire the 
bacterium via the blood meal of an infected animal (Burgdorfer et al., 1985; Magnarelli et 
al., 1992; Piesman et al., 1986). 
 
In the subsequent spring, the Borrelia-infected larva molts into a nymph. During the 
summer, the nymph is able to feed a second time. During this feeding, the nymph takes 
a blood meal from a small, uninfected mammal and will transmit the bacteria to the 
mammal thus completing the transmission cycle (Lane and Loye, 1991; Spielman, 1994; 
Steere et al., 2004). It is also during this nymphal stage that the infected tick is most 
likely to transmit B. burgdorferi to humans, which serve as accidental hosts (Lane and 
Loye, 1991). After molting into an adult, the tick feeds for the third and final time during 
the fall, usually on a large mammal such as a deer. Although deer are not competent 
reservoirs for spirochetes, larger animals are needed to feed a large number of adult 
ticks to support tick mating (Matuschka et al., 1993). 
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Figure 1. Reported Cases of Lyme Disease by Year in the United States, 1996-2010 
(CDC Division of Vector-borne Infectious Diseases).  
The number of confirmed cases and estimated probable cases of Lyme disease, as 
reported by the State Health Departments, shows an increase of incidences over time. 
There were 22,572 confirmed cases of Lyme disease in 2010, a 37% increase from 
1996. 
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Figure 2. Reported Cases of Lyme Disease in the United States, 2009 (CDC 
Division of Vector-borne Infectious Diseases).  
For each case of Lyme disease confirmed by the State Health Departments, one dot is 
placed randomly within the county of the patient’s residence. Cases have been reported 
in nearly every state, but the county of residence is not necessarily the county in which 
the infection was acquired. The greatest number of cases was reported in the 
Northeastern and the upper Northeastern states. 
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Figure 3. The enzootic life cycle of Ixodes scapularis, the tick that spreads Lyme 
disease (CDC Division of Vector-borne Infectious Diseases).  
The Ixodes tick has four stages of life: the egg, larva, nymph and adult. The egg is laid 
during the spring and hatches into larva during the summer. The larva takes a blood 
meal from a B. burgdorferi-infected small mammal or bird and then molts into a nymph 
during the subsequent spring. The infected nymph feeds another time during the spring 
or summer during which the tick transmits the bacteria to an uninfected mammalian host 
thus completing the B. burgdorferi transmission cycle. The nymph molts into an adult 
and the adult mates, takes a blood meal from a large mammal, and then lays eggs in the 
following spring to complete the lifecycle of the tick. 
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Clinical Manifestations of Lyme disease 
The clinical manifestations of Lyme disease vary depending on its progression. Early 
localized infection (Stage One) is within days to weeks following initial infection with B. 
burgdorferi. These patients may present fever, headache, fatigue and Erythema 
Chronicum Migrans. Erythema Chronicum Migrans is the red macule at the site of the 
tick bite that expands to become an annular rash that has central clearing giving the 
appearance of a bulls-eye. Following the early localized infection is the early 
disseminated infection (Stage Two), which occurs weeks or months after initial 
inoculation. Symptoms in this stage include severe neurologic and cardiac complications 
such as meningitis, encephalitis, Bells’ palsy, and transient Atrio-Venticular block. The 
last stage of the disease is late or persistent infection (Stage Three) which begins 
months to years after initial infection. Intermittent and migratory arthritis, as well as 
neurologic and musculoskeletal problems such as encephalitis and altered memory and 
speech are manifestations of persistent infection (Warinner, 2001). 
 
B. burgdorferi Structure and Genome 
B. burgdorferi belongs to a group of bacteria phylogenetically distinct from other main 
bacterial groups, the spirochetes (Woese et al., 1984). Characteristic of spirochetes B. 
burgdorferi is a long, thin helical shaped bacterium with endoflagella that give B. 
burgdorferi its characteristic helical shape (Figure 4). There are 7 to 11 flagella inserted 
near the poles of the spirochete that wind around the rod-shaped protoplasmic cylinder, 
and overlap in the center, giving the spiral shape structure as well as motility to B. 
burgdorferi (Barbour and Hayes, 1986; Charon and Goldstein, 2002; Charon et al., 2009; 
Motaleb et al., 2000; Sartakova et al., 2001). B. burgdorferi lacks lipopolysaccharide and 
has an inner and outer membrane (Takayama et al., 1987). The outer membrane, or 
cytoplasmic cylinder, surrounds both the periplasmic flagella and the protoplasmic 
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cylinder, which is composed of a peptidoglycan layer and an inner membrane enclosing 
the cytoplasmic contents (Barbour and Hayes, 1986; Johnson et al., 1984; Kudryashev 
et al., 2010; Rosa, 2005; Rosa, 1997). 
 
The genetic composition of B. burgdorferi is complex and unusual, thus creating 
obstacles for genetic studies and genetic manipulation. The segmented genome is 
composed of a linear chromosome of approximately 910 kilobases (kb) along with 
eleven circular plasmids (cp) and twelve linear plasmids (lp) totaling approximately 610 
kb (Casjens, 2000; Fraser et al., 1997). B. burgdorferi has the largest number of 
plasmids of any characterized genome. The plasmids are numbered according to their 
size in kb pairs. The sequenced B. burgdorferi strain B31 contains circular plasmids cp9, 
cp26, and nine homologous plasmids (cp32-1 to cp32-9); linear plasmids lp5, lp17, lp21, 
lp25, four homologous plasmids (lp28-1 to lp28-4), lp36, lp38, lp54, lp56; and the 910 kb 
linear chromosome (Fraser et al., 1997). The stability of these plasmids varies. 
Frequently, some plasmids are lost after only a few generations of in vitro growth while 
others are stable through continuous passage (Barbour, 1988; Byram et al., 2004; 
Grimm et al., 2003; Schwan et al., 1995; Xu et al., 1996).  
 
Many of B. burgdorferi’s plasmids encode essential functions which are required for the 
spirochete to complete its natural infectious cycle (Labandeira-Rey et al., 2003; 
Labandeira-Rey and Skare, 2001; Lawrenz et al., 2002; Schwan et al., 1988; Xu et al., 
1996). Two plasmids relatively unstable during in vitro culture growth, which are also 
essential for persistent infection within the mammalian host, are lp25 and lp28-1 
(Labandeira-Rey et al., 2003; Purser and Norris, 2000). B. burgdorferi lacking lp25 
cannot grow in wild-type mice, severe combined immunodeficient (SCID) mice, or within 
dialysis membrane chamber (DMC) implants suggesting a physiological defect. The lp25 
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plasmid contains the gene pncA, encoding for a nicotinamidase, which is likely to have a 
role for biosynthesis of NAD that is essential for in vivo growth, but not required for in 
vitro growth (Purser et al., 2003; Purser and Norris, 2000).  
 
Similarly to lp25, the lp28-1 plasmid is also essential for the persistent infection in mice 
(Grimm et al., 2004a). In B. burgdorferi, the lp28-1 plasmid contributes to the 
spirochete’s ability to persistently infect the host by encoding for VlsE (Vmp-like 
sequence E). Vmp stands for variable major protein and contributes to the antigenic 
variation of proteins in spirochetes (Barbour, 1993). VlsE is able to cause antigenic 
variation by undergoing an extensive genetic recombination mechanism at the vls-locus 
(Coutte et al., 2009; Zhang and Norris, 1998). 
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Figure 4. The spirochete B. burgdorferi and schematic of its structure (Rosa et al., 
2005). 
(A) The scanning electron micrograph (left) showing the morphology of B. burgdorferi 
and the cross-sectional view of the transmission electron micrograph (right) showing the 
helical shape imparted by the periplasmic flagella. (B) Schematic of the spirochete 
illustrating the bundles of 7 to 11 flagella wound around the protoplasmic cylinder, 
overlapping in the middle, with the insertion points near the poles of the cell. The flagella 
are enclosed within the periplasm by the outer membrane. (C) The protoplasmic cylinder 
is enclosed by the cytoplasmic membrane and a peptidoglycan layer. The endoflagella 
are inserted into the cytoplasmic membrane and extend through the cell wall into the 
periplasm, the space between the cytoplasmic and outer membranes. 
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Lipoprotein Role in Virulence 
B. burgdorferi is a Gram-negative-like bacterium that contains an inner and outer 
membrane, but unlike Gram-negative bacteria, B. burgdorferi lacks lipopolysaccharide 
(LPS) (Takayama et al., 1987). Rather than LPS, Borrelia contains an abundance of 
lipoproteins on its outer surface (Figure 5). LPS and lipoproteins are both major 
components of the outer membrane of bacteria. In fact, B. burgdorferi has an unusually 
large amount of lipoproteins; putative lipoproteins comprise as much as 14.5% of the 
genes encoded on B. burgdorferi’s plasmids, suggesting the lipoproteins play an 
important role in virulence (Casjens, 2000). Of all the open reading frames predicted in 
B. burgdorferi, lipoproteins account for 7.8% and this number is much higher than other 
bacterial genomes such as Treponema pallidum, 2.1%, or Helicobacter pylori containing 
1.3% (Casjens, 2000; Fraser et al., 1997; Setubal et al., 2006).  
 
Lipoproteins are membrane-anchored proteins found in Borrelia that are peripherally 
tethered to the lipid bilayer leaflets of the inner or outer membranes via the lipoprotein’s 
acyl group of the terminal cysteine. The lipoprotein begins as a prolipoprotein precursor 
within the cytoplasm. Next, the prolipoprotein is translocated through the inner 
membrane via a sec-dependent transport mechanism, and the ABC transporter-like 
complex, LolCDE, releases the outer membrane-targeted lipoproteins from the inner 
membrane (Yakushi et al., 2000). After release from the inner membrane, while in the 
periplasm, the lipids are modified to form mature lipoproteins containing a lipid-modified 
N-terminus. Lipoprotein maturation is suggested to occur in three steps: 1) 
diacylglyceryltransferase transfers a diacylglyceride to the sulfur of the cysteine side 
chain as specified by the signal sequence LXYC on the unmodified prolipoprotein; 2) 
signal peptidase II cleaves at the amino side of the cysteine residue to form a 
prolipoprotein; and 3) transacylase adds a third fatty acid to the new amino terminus via 
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an amide linkage to form the mature lipoprotein (Fraser et al., 1997; Hayashi and Wu, 
1990; Juncker et al., 2003). The periplasmic chaperone, LolA, forms a complex with the 
lipoprotein and crosses through the periplasm (Yokota et al., 1999). Next, this complex 
interacts with LolB, a receptor on the outer membrane, mediating the anchor of 
lipoproteins to the inner leaflet of the outer membrane (Yokota et al., 1999). The 
lipoprotein is flipped across the outer membrane through an unidentified outer 
membrane module. 
 
The most abundant lipoproteins are outer surface lipoproteins (Osp). Of these Osps, the 
most well-known of these outer surface proteins are OspA, OspB, OspC, OspD, OspE 
and OspF (Bergstrom et al., 1989; Burgdorfer et al., 1983; Howe et al., 1985; Lam et al., 
1994; Wilske et al., 1993; Zumstein et al., 1992). Other lipoproteins include decorin-
binding proteins (Dbp), Borrelia glycosaminoglycan-binding proteins (Bgp), and the VlsE. 
Interestingly Borrelial lipoproteins and Gram-negative bacteria’s LPS share similar roles: 
1) they induce the host inflammatory response and are targets for bactericidal 
antibodies; 2) they contribute to the stability and structural integrity of the bacteria; and 
3) they act as adhesions. Osps also have additional functions not shared by LPS: they 
are able use lipoproteins to 1) adapt to the various host environments; 2) evade 
phagocytosis by the host immune system; and 3) acquire nutrients (Liang et al., 2002).  
 
Borrelial lipoproteins and Gram-negative bacteria’s LPS activate the mammalian host’s 
innate immune system. Borrelia’s activation of the host immune system is achieved via 
toll-like receptor II (TLR2) and toll-like receptor I (TLR1), whereas toll-like receptor IV 
(TLR4) recognizes the LPS of Gram-negative bacteria. TLR2 heterodimerizes with TLR1 
to recognize triacyl-lipoproteins. The pattern recognition receptors of TLR2 recognize 
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Borrelial lipoproteins and activate the host’s inflammatory mediators to elicit the 
inflammatory response at the site of infection (Hirschfeld et al., 1999).  
 
Also similarly to LPS, Osps play a role in the structural integrity of the bacteria. 
Throughout its lifecycle, B. burgdorferi must transition to and survive within many 
chemically different environments within its tick and the mammalian hosts. To respond to 
and adapt to these various environments, the bacteria undergo drastic adaptive changes 
through differential gene expression to alter its surface lipoprotein expression profile 
(Brooks et al., 2003; de Silva and Fikrig, 1997; Indest et al., 2000; Liang et al., 2002; Pal 
et al., 2004b; Seshu and Skare, 2000). The absence of Osps lead to a weak bacterial 
membrane, however addition of Osps is able to restore the structural integrity of the 
lipoprotein (Xu et al., 2008). 
 
Another characteristic shared with LPS is the lipoprotein’s ability to function as an 
adhesion molecule used in bacterial transport and binding. Several lipoproteins have 
various adherence capabilities. Bgp is able to bind heparin sulphate and plays a role in 
mammalian infection (Parveen et al., 2003; Parveen and Leong, 2000). BBK32 is a 
lipoprotein that is able to bind fibronectin to promote Borrelia attachment to 
glycosaminoglycans and is important for dissemination (Probert and Johnson, 1998; 
Seshu et al., 2006). OspA is a lipoprotein that is able to attach to a protein within the tick 
gut, which is important for Borrelia colonization within the tick (Pal et al., 2000). 
Lipoproteins play a major role in Borrelia adhesion in a similar manner that LPS plays in 
adherence for Gram negative bacteria.  
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Figure 5. Membrane structure of Gram-negative bacteria and Borrelia. 
Both Gram-negative bacteria and Borrelia contain an inner membrane and outer 
membrane with a peptidoglycan layer located within the periplasmic space. Gram-
negative bacteria contain LPS on the outer surface whereas Borrelia lacks LPS. Rather, 
Borrelia contains an abundance of lipoproteins on its outer surface. 
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Functions of the lipoproteins OspA and OspC 
Two major Osps which are highly regulated are OspA and OspC; both are located on the 
outer membrane of B. burgdorferi. OspA and OspC are reciprocally regulated throughout 
the lifecycle of B. burgdorferi. B. burgdorferi residing within the midgut of unfed ticks 
have OspA present, while OspC is absent. However, upon a blood meal, the bacteria 
migrate from the tick midgut to the tick salivary glands to be transmitted to the 
mammalian host. During this transition, OspA is down-regulated and OspC is expressed 
(de Silva et al., 1996; Kobryn and Chaconas, 2001; Schwan and Piesman, 2000; 
Schwan et al., 1995). Some environmental and host signals affecting OspA and OspC 
expression include pH, cell density, temperature, and the presence of blood or other 
nutritional factors (Carroll et al., 2000; Carroll et al., 2003; Ramamoorthy and Scholl-
Meeker, 2001; Revel et al., 2002; Schwan et al., 1995; Tokarz et al., 2004; Yang et al., 
2004). For example, during in vitro growth cultivation at 23°C, OspC is not expressed, 
but a temperature shift to 37°C results in OspC being highly expressed. OspA, however, 
is unaffected by temperature: at both 23°C and 37°C, OspA is constitutively expressed 
which makes studying the repression of ospA difficult. 
 
The presence of OspC is essential for 1) the migration of B. burgdorferi from the tick 
vector to the mammalian host; and 2) the infection of the mammalian host (Gilbert et al., 
2007; Grimm et al., 2004b; Pal et al., 2004b; Tilly et al., 2006). Studies have shown that 
ospC mutant B. burgdorferi was not able to establish an infection in either wild-type mice 
or SCID mice. However, the ospC mutant was able to be transmitted to and establish 
infection within the tick. Therefore, OspC is not required to establish an infection within 
the tick, but OspC is essential for the invasion and infection of mammalian host (Yang et 
al., 2003a). To help facilitate the invasion of Borrelia into the mammalian host, OspC 
specifically binds Salp15. Salp15 is a tick salivary protein that blocks the mammalian 
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host’s CD4+ T-cell activation. This suppresses the host’s immune response at the site of 
the tick bite (Anguita et al., 2002; Ramamoorthi et al., 2005). In a study that compared B. 
burgdorferi without Salp15 present in the environment to B. burgdorferi with Salp15 
present, it was found that B. burgdorferi with Salp15 present have an increased bacterial 
burden and are better protected against antibody-mediated killing. This indicates that 
Salp15 assists B. burgdorferi in evading the host immune system by blocking the host’s 
CD4+ T-cell activation thereby inhibiting the IgG antibody response (Anguita et al., 2002; 
Ramamoorthi et al., 2005). 
 
OspC is required for the transmission and early infection of the mammalian host while 
OspA, on the other hand, is required for the colonization of B. burgdorferi within the tick 
(Yang et al., 2004). OspA specifically binds the tick receptor TROSPA found within the 
midgut of the tick to facilitate attachment of the spirochete to the vector midgut (Pal et 
al., 2004a). The receptor in the tick gut serves as a ligand for tethering spirochetes via 
OspA binding (Pal et al., 2000; Pal et al., 2004a). While in the midgut of an unfed tick, 
spirochetes express high levels of OspA; together OspA and the flagellin proteins 
account for one-third of the total protein in B. burgdorferi (Coleman and Benach, 1987). 
When the infected tick feeds on a vertebrate host, the bacterium multiplies within the tick 
midgut and OspA is repressed while OspC is up-regulated (Schwan et al., 1995). Little 
or no OspA is present in the B. burgdorferi transmitted to the mammalian host (Cassatt 
et al., 1998). The repression of ospA is essential during mammalian infection, because 
even low levels of OspA can elicit a humoral response by the host to cause clearance of 
the bacterium or cause great immunological pressure on the pathogen (Strother et al., 
2007; Xu et al., 2008). While OspA is not essential for early infection in mice, OspA is 
necessary for tick infection and maintenance in the midgut (Yang et al., 2004). The 
converse is true about OspC: OspC is essential for transmission to and early infection in 
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the vertebrate host, but is not necessary for the infection and maintenance within the tick 
midgut (Grimm et al., 2004b; Pal et al., 2004b).  
 
Reciprocal Production of OspA and OspC 
As mentioned previously, B. burgdorferi drastically alters its surface lipoproteins as a 
strategy to adapt to its two diverse host environments: the tick and the mammalian host 
(Anguita et al., 2002; Haake, 2000; Philipp, 1998; Schwan, 2003). In particular, during 
tick feeding, the two virulence factors OspA and OspC are reciprocally regulated and this 
coordinated regulation is believed to be important for the transmission of the spirochete 
between the tick and the mammalian host (Akins et al., 1998; de Silva et al., 1996; 
Montgomery et al., 1996; Stevenson et al., 1995). The reciprocal regulation has been 
shown in populations of cells as well as within individual cells using flow cytometry. 
Individual spirochetes coordinate the increase of OspC with the down-regulation of OspA 
(Srivastava and de Silva, 2008). 
 
Most bacterial species have several sigma factors which are able to bind to an RNA 
polymerase core to form an RNA polymerase holoenzyme. The addition of a sigma 
factor to the RNA polymerase allows for promoter recognition specificity during the 
initiation of transcription. Most bacteria have a general housekeeping sigma factor (σ70) 
which transcribes the majority of genes as well as several alternative sigma factors. The 
alternative sigma factors are able to distinguish different promoter sequences to direct 
the RNA polymerase to initiate transcription of select groups of genes in response to 
various environmental or developmental signals. B. burgdorferi contains only three 
sigma factors: RpoD (σ70), and the alternative sigma factors RpoN (σ54) and RpoS (σS) 
(Fraser et al., 1997).  
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The Response regulator protein II (Rrp2), in combination with RpoN and RpoS, forms 
the Rrp2-RpoN-RpoS regulatory network. During mammalian acquisition of Borrelia, 
Rrp2-RpoN-RpoS plays a central role in controlling the repression of OspA and the 
production of OspC as well as other differentially expressed genes in B. burgdorferi like 
decorin-binding protein A (DbpA), which facilitates Borrelia adherence to mammalian 
extracellular matrix, and the lipoprotein BBK32 that binds to mammalian fibronectin to 
facilitate spirochete acquisition (Figure 6) (Boardman et al., 2008; Caimano et al., 2007; 
Hubner et al., 2001; Yang et al., 2003a). The Rrp2-RpoN-RpoS pathway becomes 
activated through a cognate sensor histadine kinase Hk2 (gene BB0764) or acetyl 
phosphate(Xu et al., 2010) sensing environmental signals and activating Rrp2 (gene 
BBE0763) via phosphorylation. Signals such as low pH, elevated temperature and CO2 
concentration, high cell density and the presence of host signals are known to activate 
the pathway upon tick feeding (Akins et al., 1998; Burtnick et al., 2007; Caimano et al., 
2007; Carroll et al., 1999; Indest et al., 1997; Stevenson et al., 1995; Yang et al., 2003b). 
Rrp2 is an NtrC-like bacterial two-component response regulator that functions as an 
enhancer binding protein (EBP) dependent on RpoN to activate transcription. Together, 
RpoN and the phosphorylated Rrp2 control the transcription of RpoS, a second 
alternative sigma factor. RpoS then up-regulates many genes, including ospC, and 
represses others, like ospA, via an unknown mechanism (Boardman et al., 2008; 
Caimano et al., 2007; Fisher et al., 2005; Ouyang et al., 2008; Yang et al., 2003b; Yang 
et al., 2005).  
 
A study using B. burgdorferi grown within DMC’s implanted into rat peritoneal cavities 
(the “Host-adapted model”) demonstrated that wild-type bacteria had high OspC and low 
OspA levels, a profile expected for B. burgdorferi grown within a mammal (Caimano, 
2005). However, rpoS mutants grown in the Host-adapted model were not able to 
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repress ospA nor express ospC implying that ospA repression and ospC activation are 
connected at the molecular level through an unknown mechanism involving RpoS. 
 
There is a second two-component response regulator predicted to be encoded by the B. 
burgdorferi genome, Response regulator protein 1 (Rrp1, gene BB0419). While Hk2 and 
the Rrp2-RpoN-RpoS pathway promote spirochete transmission from the tick to the 
mammal and early infection of the mammal, the two-component system of histadine 
kinase Hk1 (gene BB0420) and response regulator Rrp1 promotes spirochete survival 
within the fed tick midgut (Caimano et al., 2011). It is predicted that Hk1 activates Rrp1 
through phosphorylation. Rrp1, a guanylatecyclase, is responsible for the synthesis of 
the second messenger bis-(3’-5’)-cycle dimericguanosine monophosphate (c-di-GMP) 
which affects the production and activity of Borrelial virulence factors such as those 
responsible for glycerol transport (He et al., 2011; Rogers et al., 2009; Ryjenkov et al., 
2005). Because ospA becomes upregulated during transmission from the mammal to the 
tick, an Rrp1 activation condition, the Rrp1 pathway may contribute to the activation of 
ospA. 
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Figure 6. The Rrp2-RpoN-RpoS regulatory network, σ54-σS sigma factor cascade, 
controls the inverse production of OspA and OspC. 
An unfed, infected tick takes a blood meal from a mammal and engorges with blood. In 
the fed, infected tick as well as the infected mammal, the Rrp2-RpoN-RpoS pathway is 
activated in B. burgdorferi upon response regulator Rrp2 phosphorylation by histadine 
kinase Hk2. Rrp2 in conjunction with RpoN activates transcription of RpoS. RpoS 
activates outer surface lipoprotein C (OspC) and OspC-related genes like decorin-
binding protein A (DbpA) and the fibronectin-binding protein (BBK32). RpoS represses 
OspA via an unknown mechanism. The Rrp2-RpoN-RpoS pathway is not activated in the 
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unfed, infected tick. The mechanism of OspA expression is also not known (←, positive 
activation; Ⱶ, negative activation). 
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Genetic Regulation of ospA 
The signals and pathways by which ospA is expressed and the mechanism by which 
RpoS represses ospA have not been fully elucidated. OspA and OspB are encoded by a 
two-gene operon, the ospAB operon (genes BBA15 and BBA16), located on the lp54 
plasmid (Figure 7) (Howe et al., 1986). The RpoD promoter drives the expression of the 
ospAB operon (Sohaskey et al., 1999). RpoD is a major sigma factor within B. 
burgdorferi and is constitutively expressed. While the expression of ospA has not been 
fully elucidated, it is known that the σ70-driven ospAB promoter contains three putative 
cis-elements: an inverted repeats (IR) region, a direct repeats (Rept) region, as well as a 
thymine rich (T-Rich) region (Sohaskey et al., 1999). Sohaskey et al. (1999) used the 
chloramphenicol acetyltransferase (CAT) reporter to show deletion of the T-Rich region 
of the ospAB promoter results in a decrease in reporter expression. Xu et al. (2010) 
demonstrated, by measuring ospA transcript of the ospA reporter within an ospAB 
mutant, that the Repeats and the T-Rich regions of the ospAB promoter are required for 
the full expression of ospA.  
 
The alternative sigma factor RpoS, which is controlled through the Rrp2-RpoN-RpoS 
pathway, is required for ospA repression (Caimano et al., 2005; Yang et al., 2003a). It is 
postulated that RpoS represses ospA either indirectly or directly (Figure 8). A possible 
method by which RpoS could indirectly repress ospA is by controlling the expression of 
an unknown ospA repressor that binds to the ospAB promoter cis-element required for 
ospA repression. This would subsequently prevent the transcription of ospA by blocking 
access of the RpoD-containing holoenzyme to the ospAB promoter. Conversely, RpoS 
could bind directly to the ospAB promoter in the presence of an accessory factor that is 
specific to in vivo cultivation, the only condition in which ospA is repressed. RpoS could 
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then bind to the promoter blocking the RpoD-dependent transcription of ospA (Caimano 
et al., 2005). 
 
In this study we seek to determine the cis-elements required for the repression and the 
activation of the ospAB promoter. A previous study by Sohaskey et al., used the 
transient CAT reporter system to evaluate which cis-elements were required for the 
activation of ospA. Their studies suggest that the T-Rich region is required for the full 
activation of ospA, however these studies were done using a transient, nonreplicating 
reporter. This reporter is transient because it does not replicate upon bacteria replication 
and is therefore an unstable reporter. Our goal is to develop a stable, replicating reporter 
system to more accurately determine which cis-elements play a role in the regulation of 
ospA. Another goal of these studies is to use our stable reporter system to identify the 
trans-factors required for the full activation and repression of ospA. And lastly, we want 
to develop an in vitro model to study ospA repression. Studying ospA repression has 
been proven tedious as the only way to acquire Borrelia with repressed ospA is to 
cultivate Borrelia in in vivo conditions. Cultivating Borrelia in vivo produces low yields of 
bacteria, so it is difficult to collect enough bacteria to use in experiments. The overall 
goal of our studies is to further elucidate the mechanisms by which ospA is regulated. 
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Figure 7. The ospAB operon the putative regulatory cis-elements in the upstream 
region of the ospA gene. 
(A) Schematic of the ospAB operon located on the B. burgdorferi linear plasmid 54. (B) 
Inverted arrows (>> and <<) denote the inverted repeat element (IR); arrowheads (>>) 
denote the repeats element (Rept); asterisks (*) denote the T-Rich element (T-Rich). 
The -35 and -10 promoter elements, ribosomal-binding site (RBS), and the ATG start 
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codon (Met) are underlined. Arrows (→) indicate the 3’ primer (P3’) and 5’ primers (PFL; 
PΔIR; PΔIR,Rept ; or PΔIR,Rept,T-Rich) used to create the four ospAB promoter constructs shown 
below. (C) Schematic representation of the ospAB promoter deletion constructs 
controlling luciferase or ospA expression All four ospAB promoter constructs are 
denoted by the prefix PospAB- followed by the name of the corresponding deletion 
(indicated at the left) with the size of the resulting promoter (indicated at the right) in 
base pairs (bp). The full-length promoter (PospAB-FL) contains all three putative cis-
elements; PospAB-∆IR contains the Repeats and the T-Rich regions; PospAB-∆IR,Rept 
contains only the T-Rich element; PospAB-∆IR,Rept,T-Rich promoter does not contain 
any of the putative cis-elements; and the PospAB-T-Rich-mut is the full-length ospAB 
promoter with a mutated T-Rich region. 
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Figure 8. Proposed models for the RpoS-dependent ospA repression. 
(Left panel) RpoS controls the expression of an unknown ospA repressor protein. The 
unknown ospA repressor protein binds to the ospAB promoter at the T-Rich cis-element, 
which in turn prevents transcription of ospA by the RpoD-containing holoenzyme. (Right 
panel) Association with an in vivo-specific accessory factor allows RpoS to bind directly 
to the ospAB promoter thereby blocking RpoD-dependent transcription initiation. 
Abbreviations: RNA polymerase (RNAP), repressor (Rep), accessory factor (AF). 
  
 
 
27 
HYPOTHESIS 
 
Based on the previous literature concerning ospA regulation, I propose the following: 
First, I hypothesize that either the IR, Repeats, or T-Rich regions on the ospAB promoter 
are key components required for the full activation or repression of ospA. The rationale 
behind this hypothesis is based on previous literature which states these three regions 
are highly conserved suggesting that they are of importance (Sohaskey et al., 1999).  
 
Second, ospA is being repressed either directly or indirectly by RpoS. Previous literature 
has shown that RpoS is required for ospA repression (Caimano et al., 2005). This 
suggests that either RpoS is able to directly bind to the ospAB promoter to prevent RpoD 
from initiating transcription or RpoS is able to control the expression of an unknown 
ospA repressor.  
 
Third, I hypothesize that an in vitro model can be created to study ospA repression. 
ospA is constitutively expressed in vitro. In B. burgdorferi, the abrogation of ospAB 
results in the constitutive expression of RpoS (He et al., 2008). Since RpoS mediates the 
repression of ospA either directly or indirectly, an ospAB mutant would have RpoS 
constitutively expressed thereby creating ospA repression conditions. In order to 
measure ospA repression within the ospAB mutant, a luciferase reporter can be placed 
under the control of an ospAB promoter to measure the ospAB promoter activity and 
thus allow for a novel method to study ospA repression in vitro.  
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CHAPTER TWO: MATERIALS AND METHODS 
 
Bacterial Strains and Growth Conditions 
The bacterial strains used in this study are described in Table 1. The TOP10 E. coli 
strain (Invitrogen, Carlsbad, CA) was used as the cloning host. B. burgdorferi clones 13A 
and BbAH130 as well as the ospAB mutant strain were described previously (He et al., 
2008; Hubner et al., 2001; Xu et al., 2007; Yang et al., 2004). The B31 13A strain was 
isolated by serially diluting a wild-type B. burgdorferi strain B31 5A13 to identify a single 
clone which lost lp25 and lp56 but retained the remaining 19 plasmids of the B. 
burgdorferi genome. This clone, 13A, is more easily transformable because it lost the 
lp25 and lp56 plasmids which contain restriction enzymes that negatively affect 
transformation efficiency (Lawrenz et al., 2002). BbAH130 is an infectious strain derived 
from plating a low passage 297 strain on Barbour-Stoenner-Kelly (BSK) agar medium. B. 
burgdorferi 297 is an infectious strain which was isolated from the cerebrospinal fluid of 
a patient with Lyme disease (Yang et al., 2004). The ospAB mutant strain (ΔospAB) was 
previously generated by electroporating the suicide vector, pXT-OspA-Strep, into the B. 
burgdorferi strain BbAH130. The suicide vector underwent homologous recombination 
with the wild-type Borrelia genome to insert the streptomycin-resistance gene (aadA) 
into the native ospA gene thus inactivating the ospAB operon.  
 
E. coli cultures were grown with appropriate antibiotics at 37°C with aeration in Miller 
Difco Luria Bertani (LB) broth (Becton, Dickinson and Company, Sparks, MD) or grown 
on LB plates consisting of LB broth with 2% agar. Kanamycin concentrations for both LB 
broth and LB agar were 50 µg ml-1 while ampicillin was 100 µg ml-1. Borrelia were 
cultivated in vitro at 37°C with 5% CO2 in BSK medium (Sigma, St Louis, MO) 
supplemented with 6% normal rabbit serum (Pel-Freez Biologicals, Rogers, AR). 
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Antibiotic concentrations used to select for mutants were 300 μg ml−1 for kanamycin and 
100 μg ml−1 for streptomycin. Dark-field microscopy was used to enumerate spirochetes. 
Cultures were harvested at mid-logarithmic phase of growth (approximately 3×107 
spirochetes ml−1), unless otherwise noted. For the norepinephrine studies, cultures were 
grown to mid-log in 10 ml BSK, split equally into two 5ml cultures and then centrifuged at 
4000 x g for 20 minutes. The pellets were suspended into either BSK only or BSK with 
the addition of norepinephrine bitartrate (Sigma) to a final concentration of 10µM. After 
suspension, cultures were grown for 48 hours before harvesting. 
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Table 1. Strains and plasmids used in this study. 
Plasmid or Strain Description Source 
Plasmids 
  
 
pBSV2 
B. burgdorferi/E. coli shuttle vector with native 
ospAB 
(He et al., 
2008) 
 
pOspA 
pBSV2 with full-length ospAB promoter 
controlling native ospA 
(He et al., 
2008) 
 
pOspAB 
pBSV2 with full-length ospAB promoter 
controlling native ospAB 
(He et al., 
2008) 
 
pOspAB-∆IR pOspA carrying PospAB-∆IR controlling OspA This study 
 
pOspAB-ΔIR,Rept 
pOspA carrying PospAB-∆IR,Rept controlling 
OspA 
This study 
 
pOspAB-ΔIR,Rept,T-Rich 
pOspA carrying PospAB-∆IR,Rept,T-Rich 
controlling OspA 
This study 
 
pOspAB-T-Rich-mut 
pOspA carrying PospAB-T-Rich-mut 
controlling OspA 
This study 
 
pJD48 
B. burgdorferi/E. coli shuttle vector with a 
luciferase reporter under control of no 
promoter 
(Blevins et 
al., 2007) 
 
pLuc-PflaB 
pJD48 carrying flaB promoter controlling 
luciferase 
This study 
 
pLuc-FL 
pJD48 carrying PospAB-FL controlling 
luciferase 
This study 
 
pLuc-∆IR 
pJD48 carrying PospAB-No-IR controlling 
luciferase 
This study 
 
pLuc-∆IR,Rept 
pJD48 carrying PospAB-No-IR,Rept 
controlling luciferase 
This study 
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pLuc-∆IR,Rept,T-Rich 
pJD48 carrying PospAB-No-IR,Rept,T-Rich 
controlling luciferase 
This study 
 
pLuc-T-Rich-mut 
pJD48 carrying PospAB-T-Rich-mut 
controlling luciferase 
This study 
B. burgdorferi Strains 
  
 
13A Clone derived from B. burgdorferi B31 5A13 
(Xu et al., 
2007) 
 
AH130 Clone derived from B. burgdorferi RJ297 
(Hubner et 
al., 2001) 
 
∆ospAB ospAB mutant 
(Yang et al., 
2004) 
 
AH130/pJD48 AH130 receiving pJD48 This study 
 
AH130/pLuc-PflaB AH130 receiving pLuc-PflaB This study 
 
AH130/pLuc-FL AH130 receiving pLuc-FL This study 
 
AH130/pLuc-∆IR AH130 receiving pLuc-∆IR This study 
 
AH130/pLuc-∆IR,Rept AH130 receiving pLuc-∆IR,Rept This study 
 
AH130/pLuc-∆IR,Rept,T-
Rich 
AH130 receiving pLuc-∆IR,Rept,T-Rich This study 
 
AH130/pLuc-T-Rich-mut AH130 receiving pLuc-T-Rich-mut This study 
 
13A/pJD48 13A receiving pJD48 This study 
 
13A/pLuc-PflaB 13A receiving pLuc-PflaB This study 
 
13A/pLuc-FL 13A receiving pLuc-FL This study 
 
13A/pLuc-∆IR 13A receiving pLuc-∆IR This study 
 
13A/pLuc-∆IR,Rept 13A receiving pLuc-∆IR,Rept This study 
 
13A/pLuc-∆IR,Rept,T-
Rich 
13A receiving pLuc-∆IR,Rept,T-Rich This study 
 
13A/pLuc-T-Rich-mut 13A receiving pLuc-T-Rich-mut This study 
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∆ospAB/pOspAB ∆ospAB receiving pOspAB This study 
 
∆ospAB/pOspAB-∆IR ∆ospAB receiving pOspAB-∆IR This study 
 
∆ospAB/pOspAB-
∆IR,Rept 
∆ospAB receiving pOspAB-∆IR,Rept This study 
 
∆ospAB/pOspAB-
∆IR,Rept,T-Rich 
∆ospAB receiving pOspAB-∆IR,Rept,T-Rich This study 
 
∆ospAB/pJD48 ∆ospAB receiving pJD48 This study 
 
∆ospAB/pLuc-PflaB ∆ospAB receiving pLuc-PflaB This study 
 
∆ospAB/pLuc-FL ∆ospAB receiving pLuc-FL This study 
 
∆ospAB/pLuc-∆IR ∆ospAB receiving pLuc-∆IR This study 
 
∆ospAB/pLuc-∆IR,Rept ∆ospAB receiving pLuc-∆IR,Rept This study 
 
∆ospAB/pLuc-
∆IR,Rept,T-Rich 
∆ospAB receiving pLuc-∆IR,Rept,T-Rich This study 
 
∆ospAB/pLuc-T-Rich-mut ∆ospAB receiving pLuc-T-Rich-mut This study 
 
∆ospAB/rrp2G239C ∆ospAB with rrp2 point mutation 
(He et al., 
2008) 
 
∆ospAB/∆rpoN ∆ospAB with inactivated rpoN 
(He et al., 
2008) 
 
∆ospAB/∆rpoS ∆ospAB with inactivated rpoS 
(He et al., 
2008) 
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Generation of Native OspA Reporter Vectors 
The plasmid pOspAB is a shuttle vector containing origins of replication for both E. coli 
(ColE1) and B. burgdorferi (cp9) as previously described (He et al., 2008; Yang et al., 
2004). pOspAB contains the native ospA gene as a reporter under the control of the full-
length ospAB promoter containing all three of the putative cis-elements. The plasmid 
also has a kanamycin resistance marker. To construct shuttle vectors with various 
deletions of the ospAB promoter controlling the ospAB reporter, multiple polymerase 
chain reactions (PCR) were performed using the primer sets indicated in Table 2. 
pOspAB, containing the full-length ospAB promoter, served as the cloning template. 
Each PCR reaction used Taq DNA Polymerase (New England BioLabs) and the same 3’ 
primer, ospAB-Down-3'-SacI, but different 5’ primers. The 5’ primers were used in the 
reactions to create various length ospAB promoter fragments as noted in the ΔIR 
promoter removed the IR region from the full-length ospAB promoter; the ΔIR,Rept 
promoter removed the promoter segment encompassing the IR and the Repeat region of 
the ospAB promoter; and the ΔIR,Rept,T-Rich promoter removed the promoter segment 
encompassing each of the three putative cis-elements from the ospAB promoter.  
 
During PCR amplification of the various promoters, the 3’ primer ospAB-Down-3’-SacI 
introduced a SacI restriction site to the 3’ end of the resulting fragments while each of 
the 5’ primers introduced an XbaI restriction site at the 5’ end (Table 2). The resulting 
PCR fragments (ΔIR, ΔIR,Rept, and ΔIR,Rept,T-Rich) were cloned into the pSC-A-
amp/kan TA cloning vector (Stratagene, La Jolla, CA) to create the plasmids. Blue/white 
screening was used to select for transformants by spreading 40 µl of 40 μg ml−1X-gal 
dissolved in dimethylformamide on top of the agar plates containing ampicillin. The three 
resulting plasmids and the parental plasmid pOspAB were digested with SacI and XbaI 
and then ligated together to create pOspAB-∆IR, pOspAB-∆IR,Rept, and pOspAB-
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∆IR,Rept,T-Rich (Table 1). These plasmids have various ospAB promoters site-
directionally inserted upstream of the ospAB gene to control the transcription of ospAB. 
pOspAB has the full-length ospAB promoter containing all three of the putative cis-
elements: the IR, Repeats and T-Rich regions. The pOspAB-∆IR contains the Repeat 
and the T-Rich regions, but not the IR. The pOspAB-∆IR,Rept contains the T-Rich region 
but lacks the IR and Repeats regions. pOspAB-∆IR,Rept,T-Rich lacks all three of the 
putative cis-elements: IR, Repeats, and T-Rich.  
 
Site-directed mutagenesis was performed by Genscript (Piscataway, NJ) to mutate the 
T-Rich region of the full-length ospAB promoter. The T-Rich region’s 10 bp sequence 
“TTATTTTTT” of the plasmid pOspAB was mutated to the 10 bp sequence 
“CGCGGCCGCG” to create the plasmid pOspAB-T-Rich-mut. This plasmid contains 
ospAB expressed by the PospAB-T-Rich-mut promoter, which is the full-length ospAB 
promoter with a mutated T-Rich region.  
 
To place the PospAB-T-Rich-mut promoter controlling luciferase expression, PCR 
amplification of the plasmid pOspAB-T-Rich-mut using the primers ospA-FL-BglII and 
ospA-ATG-3-NdeI was performed (Table 2). The resulting promoter fragment and the 
pJD48 plasmid were digested with NdeI and BglII and then ligated to create the plasmid 
pLuc-T-Rich-mut. This plasmid contains luciferase expressed by the full-length ospAB 
promoter with a mutated T-Rich region.  
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Table 2. Primers used in this study. 
 
  
Primer name Sequence (5' to 3') Purpose
ospAB- No-IR-XbaI CATCTAGACATTAAATCTAAGCTTAATTAGAAC
5' primer; PCR of the ospAB  promoter 
for constructing pOspAB-ΔIR
ospAB- No-Repeat-XbaI CATCTAGACCAAACTTAATTGAAGTTATTATC
5' primer; PCR of the ospAB  promoter 
for constructing pOspAB-ΔIR,Rept
ospAB- No-T-Rich-XbaI CATCTAGAATTTTCTATTTGTTATTTGTTAATC
5' primer; PCR of the ospAB  promoter 
for constructing pOspAB-ΔIR,Rept,T-
Rich
ospAB- Down-3'-SacI CTTGAGCTCCTAAGAGACTTTTTCCAGAAGTAACA
3' primer; PCR of the ospAB  promoter 
for constructing all of above listed 
plasmids.
ospA -FL-BglII AGATCTAGACATTTAACTTTTC
5' primer; PCR of the ospAB  promoter 
for constructing pLuc-FL
ospA -No-IR-BglII CTAGATCTCATTAAATCTAAGCTTAATTAGAA
5' primer; PCR of the ospAB  promoter 
for constructing pLuc-ΔIR
ospA- No-Repeat-BglII CTAGATCTCCAAACTTAATTGAAGTTATTAT
5' primer; PCR of the ospAB  promoter 
for constructing pLuc-ΔIR,Rept
ospA- No-T-Rich-BglII CTAGATCTAATTTTCTATTTGTTATTTGTTAAT
5' primer; PCR of the ospAB  promoter 
for constructing pLuc-ΔIR,Rept,T-Rich
ospA -ATG-3-NdeI CATATGATATTCTCCTTTTATATTAATATAACTT
3' primer; PCR of the ospAB  promoter 
for constructing the four above listed 
plasmids.
FlaB-F AGATCTTACCTTGGATTTTACCGTTAAGCGC
5' primer; PCR of the flaB  promoter for 
constructing pLuc-PflaB
FlaB-R CATATGATATCATTCCTCCATGATAAAAT
3' primer; PCR of the flaB  promoter for 
constructing pLuc-PflaB
Q-HX-OspA-F TAGCAGCCTTGACGAGAAAAACAG
5' primer; PCR of the ospA  gene for qRT-
PCR
Q-HX-OspA-R TTATCAGAAGTTCCTTTAAGCTCA
3' primer; PCR of the ospA  gene for qRT-
PCR
Q-HX-FlaB-F ACCAGCATCACTTTCAGGGTCTCA
5' primer; PCR of the flaB  gene for qRT-
PCR
Q-HX-FlaB-R CAGCAATAGCTTCATCTTGGTTTG
3' primer; PCR of the flaB  gene for qRT-
PCR
*Restriction sites for purpose of cloning are highlighted in boldface letters
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Generation of Luciferase Reporter Vectors 
The previously described plasmid pJD48 was used to create the luciferase reporter 
vectors (Blevins et al., 2007). pJD48 is a shuttle vector containing a replication origin for 
B. burgdorferi (cp9) and for E. coli (ColE1). pJD48 contains an NdeI and BglII cloning 
site upstream of the luciferase gene which allows for placement of a promoter to control 
the expression of the luciferase. In addition to luciferase, pJD48 also contains a 
kanamycin-resistance marker. To create luciferase reporter constructs with varying 
length ospAB promoters, serial truncations of the ospAB promoter were created via PCR 
using four various 5’ primers and using the same 3’ primer (PospA-ATG-3-NdeI). The 5’ 
primer introduced a BglII restriction site to the 5’ PCR fragment end while the 3’ primer 
introduced an NdeI restriction site to the 3’ end of the PCR fragment; pOspA, containing 
the full-length wild-type ospAB promoter, served as the PCR template. Primer pairs are 
listed in Table 2. The resulting PCR fragments (FL; ΔIR; ΔIR,Repts; and ΔIR,Repts,T-
Rich) were cloned into the pSC-A-amp/kan TA cloning vector. The resulting plasmids 
and pJD48 were digested with NdeI and BglII and ligated together to create pLuc-FL, 
pLuc-ΔIR, pLuc-ΔIR,Repts, and pLuc-ΔIR,Repts,T-Rich (Table 1). 
  
Genetic Manipulation of Borrelia burgdorferi 
Borrelial electroporations were performed as previously described (Samuels, 1995; Yang 
et al., 2004). B. burgdorferi were recovered from -80°C frozen stock into 2mL of BSK 
medium. The culture was incubated at 34°C with 5% CO2 until the culture cell density 
was approximately 3×105 spirochetes ml-1. The culture was then transferred to 50ml BSK 
medium with appropriate antibiotics and grown until the cell density reached more than 
3×107 spirochetes ml-1. For preparation of competent cells, the Borrelia culture was 
centrifuged at 4,000 rpm for 20 minutes at 4°C and the supernatant was decanted. The 
cells were washed twice with 30 ml cold saline (0.9% sodium chloride dissolved in 
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double-distilled water) and washed an additional three times with 30 ml cold 
Electroporation Solution (EPS) which consists of 9.3% sucrose and 15% glycerol 
dissolved in double-distilled water. After the final wash, the final pellet was gently 
suspended in 50 µl of EPS and transferred to a 1.5 ml eppendorf tube. About 5-20 µg of 
plasmid DNA was added to the resuspension and the mixture was transferred to a pre-
chilled electroporation 0.2 cm cuvette (Bio-Rad) and allowed to chill on ice for at least 1 
minute. To electroporate, the cuvette was placed in the gene pulser (Gene pulser, Bio-
Rad) and a single exponential decay pulse of 2.5 kV, capacitance of 25 µF, and 
resistance of 200 Ω was allowed producing a time constant of 4 to 6 ms. Immediately 
after electroporation, 1 ml of BSK was added to the cuvette and then this was 
transferred to 35 ml BSK without antibiotics. The culture was incubated overnight at 
34°C with 5% CO2. Following overnight incubation, appropriate antibiotics were added 
and 220 µl of the 35 ml overnight culture was aliquoted into each well of a 96 well plate. 
The color of the medium in the plate wells were monitored; a change of color from red to 
yellow indicated that cells were growing, which was verified by microscopic examination 
of a sample of the cells from the well. If cell growth is confirmed, 10 µl of the positive 
culture was transferred to 2 ml or 15 ml BSK with appropriate antibiotics and then further 
analyzed and assayed. 
 
Quantitative RT-PCR 
Cultures were pelleted by centrifugation and the RNA extracted using the RNeasy mini 
kit (Qiagen, Valencia, CA) per the manufacturer’s instructions. Purified RNA was treated 
with DNase (Promega) and converted to cDNA using SuperScript III reverse 
transcriptase with random primers (Invitrogen, Carlsbad, CA) following the 
manufacturer’s instructions. Platinum SYBR green qPCR SuperMix-UDG (Invitrogen) 
along with primers specific for flaB and ospA were used to perform qPCR in triplicate on 
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the cDNA samples (Table 2). An absolute quantification method using qPCR was 
performed according to the manufacturer’s instructions (Stratagene) using the specific 
flaB primers and serial dilutions of the standard template, a cloning vector containing the 
flaB gene. Briefly, a standard curve was generated by plotting template quantity against 
the Ct values of the standards. The quantity of ospA transcript was determined by 
comparing the samples’ Ct values to the standard curve plot. The standards and 
samples were performed in triplicate using an ABI 7000 Sequence Detection System. 
 
Luciferase assays 
Luciferase assays were performed as previously described using the commercial 
luciferase assay system (Promega Corp., Madison, WI) (Blevins et al., 2007). After 
enumerating the bacteria via dark-field microscopy, bacterial cultures were centrifuged at 
4,000 rpm for 20 minutes at 4°C. The supernatant was decanted and the pellet was 
washed twice with PBS, with centrifugation at 4,000 rpm for 20 min at 4°C after each 
wash. The final pellet was transferred to a 1.5 ml Eppendorf tube and was suspended in 
100 µl of the cell culture lysis reagent (CCLR), which was supplied by the manufacturer. 
The debris were pelleted by centrifugation in a microcentrifuge at 15,000 rpm for 1 min. 
Ten microliters of lysate was aliquoted into luminometer tubes (Promega) and 50 µl of 
luciferase assay reagent was added immediately prior to beginning measurements. 
Luciferase activity was measured for 10 sec using a Centro LB 960 luminometer 
(Berthold Technologies, Oak Ridge, TN). The average background luminescence was 
subtracted from the readings and the measurement reported as relative light units 
(RLU).  
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Host-Adapted Spirochete Model 
The insertion of DMC’s containing B. burgdorferi into the peritoneal cavities of rats was 
previously described (Akins et al., 1998). Borrelia were grown to mid-logarithmic and 
then diluted in BSK to 3×103 Bb ml-1. Five milliliters of this dilution was put into a 10 kDa 
Spectra/Por dialysis membrane (Spectrum Medical Industries Inc., Los Angeles, CA) 
and inserted into the peritoneal cavity of four- to six-week-old Sprague-Dawley rats 
(Harlan, Indianapolis, IN) using strict aseptic technique. Fourteen days after 
implantation, the DMCs were harvested and its contents removed by syringe aspiration. 
Spirochetes were enumerated via dark-field microscopy and then prepared for the 
luciferase assay as described.  
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CHAPTER THREE: RESULTS 
 
Section I: The T-Rich region is required for the full activation of the ospAB 
promoter. 
 
Deletion of T-Rich element in wild-type B. burgdorferi with luciferase reporter 
results in decreased luciferase expression  
The ospAB promoter contains three putative cis-elements: the IR region, the repeats 
region, and the T-Rich region (Sohaskey et al., 1999). To determine which of these three 
putative cis-elements are required for the full activation of the ospAB promoter, the 
various length ospAB promoters PospAB-FL; PospAB-ΔIR; PospAB-ΔIR,Rept; and 
PospAB-ΔIR,Rept,T-Rich were created by PCR using pOspAB as a template. The four 
promoters are as follows: 1) the PospAB-FL promoter is the full-length ospAB promoter 
containing all three putative cis-elements; 2) the PospAB-ΔIR promoter lacks the IR 
region while retaining the Rept and T-Rich regions; 3) the PospAB-ΔIR,Rept promoter 
retains the T-Rich region but lacks the region encompassing the IR and the Rept 
elements; and 4) the PospAB-ΔIR,Rept,T-Rich promoter deletes the ospAB promoter 
region encompassing all three of the putative cis-elements. These promoters were site-
directionally cloned upstream of the luciferase open reading frame in the pJD48 shuttle 
vector to control the expression of the luciferase reporter, and then the plasmids were 
electroporated into wild-type B. burgdorferi 13A to create the strains pLuc-FL; pLuc-∆IR; 
pLuc-∆IR, Rept; and pLuc-∆IR,Rept,T-Rich, respectively.  
 
These four strains were grown in vitro at 37°C, a condition in which ospA is constitutively 
expressed, and then harvested and prepared for the luciferase assay. The effect of the 
absence of the putative cis-elements on the ospAB promoter activity was determined 
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using the luciferase assay. The luciferase assay results indicate that there was no 
significant difference in luciferase activity between the PospAB-FL promoter and the 
PospAB-ΔIR or the PospAB-ΔIR,Rept promoters (Figure 9). However, there was a 
reduction in luciferase activity in the PospAB-ΔIR,Rept,T-Rich promoter, showing that 
deletion of the T-Rich element results in a decrease of ospAB promoter activation.   
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Figure 9. Influence of cis-elements on ospAB promoter activation. 
The 13A strain electroporated with a shuttle vector containing the luciferase reporter 
under the control of either the constitutively expressed flaB promoter (PflaB), no 
promoter (none), the full-length ospAB promoter (PospAB-FL), the ospAB promoter 
lacking the IR region (PospAB-ΔIR), the ospAB promoter lacking the IR and Repeats 
regions (PospAB-ΔIR,Rept) and the ospAB promoter lacking all three putative cis-
elements (PospAB-ΔIR,Rept,T-Rich). Strains were grown in BSK at 37°C and prepared 
for luciferase assay (*, p<0.05 using paired Student’s t-test). 
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Deletion of T-Rich element in the ospAB mutant B. burgdorferi with ospA reporter 
results in decreased ospA transcript. 
Using various ospAB promoters controlling the luciferase reporter expression within the 
wild-type Borrelia 13A, it was determined that deletion of the T-Rich region results in 
decreased activation of the ospAB promoter. To confirm this finding, we used a similar 
approach to measure ospAB promoter activity, but employed a native ospAB reporter 
rather than using the luciferase reporter.  
 
The various length ospAB promoters PospAB-FL; PospAB-ΔIR; PospAB-ΔIR,Rept; and 
PospAB-ΔIR,Rept,T-Rich were site-directionally cloned upstream of the ospAB open 
reading frame in the pOspAB shuttle vector to control the expression of the ospAB 
reporter. The plasmids were electroporated into ospAB mutant Borrelia to create the 
strains pOspAB-FL; pOspAB-∆IR; pOspAB-∆IR, Rept; and pOspAB-∆IR,Rept,T-Rich, 
respectively. The resulting strains were grown in vitro at 37°C, a condition in which ospA 
is highly expressed. The cultures were harvested and then prepared for analysis by 
qRT-PCR. 
 
The ospA transcript number was measured relative to the flagellin (flaB) transcript which 
is constitutively expressed. The results show that deletion of the IR or deletion of the IR 
and Rept regions together did not result in a significant decrease of ospA transcript 
compared to the full-length promoter (Figure 10). However, deletion of the IR, Rept and 
T-Rich regions combined showed a decrease in the ospA transcript level compared to 
the full-length promoter suggesting that the T-Rich region is required for the full 
activation of ospA. This result is in agreement with our previous finding using the 
luciferase reporter.  
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Figure 10. ospA transcript levels of the various ospAB promoters controlling 
expression of ospAB within the ospAB mutant B. burgdorferi. 
The B. burgdorferi ospAB mutant with a shuttle vector containing the ospAB reporter 
under the control of either the full-length ospAB promoter (PospAB-FL), the ospAB 
promoter lacking the IR region (PospAB-ΔIR), the ospAB promoter lacking the IR and 
Repeats regions (PospAB-ΔIR,Rept) and the ospAB promoter lacking all three putative 
cis-elements (PospAB-ΔIR,Rept,T-Rich). Strains were grown in BSK at 37°C and 
prepared for qRT-PCR. Transcript relative to copies of flagellin, flaB (*, p<0.05 using 
paired Student’s t-test). 
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Mutation of the T-Rich element in wild-type B. burgdorferi with luciferase reporter 
results in decreased luciferase expression  
Next, we wanted to further dissect the ospAB promoter. The promoters used to show 
that the T-Rich region is required for the full activation have multiple elements missing 
and not just the T-Rich region. To ensure that the effect we have seen is dependent 
solely on the T-Rich region and not a combination of the T-Rich element and the IR or 
Rept elements, we used site-directed mutagenesis to mutate only the T-Rich region. 
 
Site-directed mutagenesis was used to replace the 10 bp sequence “TTATTTTTTT” of 
the T-Rich region with a different 10 bp sequence “CGCGGCCGCG” to create the 
promoter PospAB-T-Rich-mut. This promoter was site-directionally cloned upstream of 
the luciferase open reading frame in the pJD48 shuttle vector and then transformed into 
the 13A B. burgdorferi strain and grown in vitro at 37°C. The luciferase expression level 
of the PospAB-T-Rich-mut promoter was compared to the PospAB-FL. The PospAB-T-
Rich-mut promoter had significantly reduced levels of luciferase (Figure 11). The 
reduction in the ospAB promoter expression caused by the mutagenesis of the T-Rich 
region indicates that the T-Rich region alone is responsible for the full expression of 
ospA. Together, these studies show that the T-Rich region is required for the full 
activation of ospA. 
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Figure 11. Influence of the T-Rich cis-element on ospAB promoter activation. 
The 13A strain electroporated with a shuttle vector containing the luciferase reporter 
under the control of either the constitutively expressed flaB promoter (PflaB), the full-
length ospAB promoter (PospAB-FL), and the PospAB-FL promoter with a mutated T-
Rich region (PospAB-T-Rich-mut). Strains were grown in BSK at 37°C and prepared for 
luciferase assay (*, p<0.05 using paired Student’s t-test).  
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Section II: Establishment of an in vitro model of ospA repression 
 
Abrogation of ospAB results in constitutive activation of ospC 
OspA and OspB are major surface lipoproteins in B. burgdorferi. During mammalian 
infection, OspC is produced while OspA is repressed. However, the inverse regulation is 
true during the infection of ticks: OspA is produced while OspC is not. A previous study 
by Yang et al. (2004) abrogated OspAB by disrupting the ospAB operon. Their studies 
demonstrated that the ospAB mutant was able to infect mice but was not able to 
colonize or replicate in ticks (Yang et al., 2004). In addition to this finding, we observed 
that the deletion of ospAB within B. burgdorferi results in the increased, constitutive 
expression of ospC (He et al., 2009) 
 
To determine the influence of OspA and OspB on the expression of OspC, the protein 
profiles of the ospAB mutant and the wild-type parental strain BbAH130 were compared. 
The ospAB mutant and BbAH130 were grown in vitro at either 23°C, a condition in which 
OspC is not produced, or 37°C, a condition where OspC is produced. The cultures were 
harvested and the lysates were subjected to SDS-PAGE before the proteins were 
stained by Coomassie blue (Figure 12). As expected, at 23°C, the wild-type BbAH130 
did not produce OspC; at low temperatures which mimic the tick environment, OspA is 
highly expressed whereas OspC is not. At both 23°C and 37°C, the ospAB mutant did 
not produce OspA, as expected, due to the disruption of the ospAB operon. However, 
the ospAB mutant exhibited OspC production at both 23°C and 37°C. OspC is normally 
expressed at 37°C, but not at 23°C. These results show that OspC is constitutively 
expressed in the ospAB mutant regardless of temperature. 
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In addition to determining the effect of ospAB abrogation on OspC, the effect of ospAB 
abrogation on other differentially expressed lipoproteins was also evaluated. Decorin-
binding protein (DbpA), fibronectin-binding protein (BBK32), and multicopy lipoprotein-8 
(Mlp8) are all lipoproteins which are known to be expressed at 37°C, but not at 23°C (He 
et al., 2007; Hubner et al., 2001; Yang et al., 2007). To determine if expression of these 
temperature-induced lipoproteins was affected by the abrogation of ospAB, immunoblot 
assays were performed on the wild-type BbAH130 and ospAB mutant whole cell lysates 
from cultures grown at 23°C. Antibodies specific to the differentially expressed 
lipoproteins DbpA, BBK32, Mlp-8 as well as OspC were used. FlaB, the constitutively 
expressed flagellin protein, served as the protein loading standard. The lipoproteins 
DbpA, BBK32 and Mlp-8 were not present or in low presence in the wild-type BbAH130, 
however, they were abundantly produced in the ospAB mutant (Figure 13). These 
results demonstrate that in addition to ospC being constitutively expressed in the ospAB 
mutant grown at 23°C, dbpA, bbk32 and mlp-8 are constitutively expressed or 
upregulated in the ospAB mutant. 
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Figure 12. Abrogation of ospAB results in constitutive activation of ospC (He et 
al., 2009). 
The wild-type clone BbAH130 (wt) and the isogenic ospAB mutant (ΔospAB) were grown 
in BSK medium at either 23°C (23) or 37°C (37). Cultures were harvested at mid-
logarithmic phase, and cell lysates were subjected to SDS-PAGE before the protein was 
stained with Coomassie blue. The molecular mass markers are indicated at the left of 
the figure in kilodaltons (kDa). Protein bands corresponding to OspA and OspC are 
labeled on the right. 
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Figure 13. Abrogation of ospAB influences the production of lipoproteins (He et 
al., 2009). 
The wild-type clone BbAH130 (wt) and the isogenic ospAB mutant (ΔospAB) were grown 
in BSK medium at 23°C. Cultures were harvested at mid-logarithmic phase and whole 
cell lysates were probed with antibodies directed against the specific lipoprotein 
(indicated on left). FlaB is constitutively expressed and serves as the control for equal 
lysate amounts. 
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Mutation or inactivation of rpoS, rpoN or rrp2 abolishes constitutive expression of 
ospC in the ospAB mutant 
In B. burgdorferi, the Rrp2-RpoN-RpoS pathway mediates the temperature-induced 
expression of ospC, dbpA, and bbk32 (Figure 6) (Eggers et al., 2004; Gilbert et al., 
2007; He et al., 2007; Hubner et al., 2001; Yang et al., 2003a). Since abrogation of 
ospAB resulted in constitutive expression of ospC, dbpA and bbk32, and expression of 
these three lipoproteins is mediated through the Rrp2-RpoN-RpoS pathway, we 
hypothesized that the Rrp2-RpoN-RpoS regulatory pathway is constitutively activated in 
the ospAB mutant.  
 
To determine if the Rrp2-RpoN-RpoS pathway is responsible for the constitutive 
expression of ospC within the ospAB mutant, mutations in the rrp2, rpoN, or rpoS genes 
were generated in the ospAB mutant. The ospAB mutant and the double mutant cultures 
were cultivated in BSK at 35°C, harvested at mid-log and the whole cell lysates 
subjected to SDS-PAGE before staining with Coomassie blue. The rrp2 point mutation, 
the inactivated rpoN and the inactivated rpoS in the ospAB mutant resulted in decreased 
constitutively expressed OspC production compared to the wild-type or the ospAB 
mutant (Figure 14). These results indicate that ospC is constitutively expressed due to 
the Rrp2-RpoN-RpoS pathway being constitutively expressed upon abrogation of 
ospAB. 
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Figure 14. Constitutive expression of OspC in the ospAB mutant is abolished 
upon mutation or inactivation of rpoS, rpoN or rrp2 (He et al., 2008). 
The ospAB single mutant (ΔospAB), and the ospAB double mutants of rpoS (ΔrpoS), 
rpoN (ΔrpoN), and rrp2 (rrp2G239C) were cultured in BSK at 35°C, harvested at mid-log 
and the whole cell lysates subjected to SDS-PAGE before staining with Coomassie blue. 
The molecular mass markers are indicated at the left of the figure in kilodaltons (kDa). 
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Complementation of the ospAB mutant with a wild-type copy of ospAB or ospA 
alone restores repression of ospC at 23°C 
The constitutive activation of the Rrp2-RpoN-RpoS pathway in the ospAB mutant could 
be due to spurious mutation locking the pathway in an active state rather than the 
constitutive expression being due to the abrogation of ospAB. To ensure that the 
constitutive activation of the Rrp2-RpoN-RpoS pathway was due to the loss of ospAB 
expression, the ospAB mutant was complemented with the shuttle vector pOspAB 
carrying a wild-type copy of native ospAB. The wild-type, ospAB mutant and the ospAB 
complement were cultivated in BSK at 23°C and whole-cell lysates were subjected to 
SDS-PAGE before staining with Coomassie blue. The ospAB mutant complemented with 
ospAB was not able to constitutively produce OspC at 23°C like the ospAB mutant 
(Figure 15). This suggests that the abrogation of ospAB is responsible for the 
constitutive activation of the Rrp2-RpoN-RpoS pathway.  
 
In addition to complementing the ospAB mutant with native ospAB, the ospAB mutant 
was complemented with only ospA driven by the native ospAB promoter (pOspA) to 
determine if the absence of ospA was mainly responsible for the constitutive OspC 
production phenotype. The shuttle vector alone without ospAB or ospA, pBSV2, was 
used as a control to ensure the effects seen in pOspAB or pOspA were due to the 
shuttle vector, but rather to reintroducing ospAB and ospA. Complementation with ospA 
alone restored the temperature-dependent repression of ospC expression (Figure 15). 
Together, these data demonstrate that the abrogation of ospA, rather than spurious 
mutation, was responsible for the constitutive activation of the Rrp2-RpoN-RpoS 
regulatory pathway.  
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Figure 15. Complementing the ospAB mutant with ospAB or ospA alone restores 
ospC repression at 23°C (He et al., 2008). 
The wild-type strain (wt), the ospAB mutant (∆ospAB), the ospAB mutant complemented 
with the shuttle vector alone (∆ospAB/pBSV2), and the ospAB mutant complemented 
with the shuttle vector carrying the native copy of ospAB (∆ospAB/pOspAB) or ospA 
(∆ospAB/pOspA) were cultivated at 23°C. Whole-cell lysates were subjected to SDS-
PAGE before staining with Coomassie blue. The labeled bands on right correspond to 
OspA, OspB and OspC. The molecular mass markers are indicated at the left of the 
figure in kilodaltons (kDa). 
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Proposed model for the positive feedback circuit between the activation of the 
Rrp2-RpoN-RpoS regulatory pathway and the reduction of OspA 
The constitutive production of OspC via the Rrp2-RpoN-RpoS regulatory pathway, which 
is constitutively activated upon abrogation of ospAB, suggests a positive feedback circuit 
(Figure 16). Feedback loops have been reported in other bacteria (Guespin-Michel and 
Kaufman, 2001), and such a feedback loop could be beneficial to B. burgdorferi’s 
transmission and mammalian infection. Given our results, we hypothesize that the Rrp2-
RpoN-RpoS regulatory pathway is activated during tick feeding by an unknown signal. 
The activation of the Rrp2-RpoN-RpoS pathway results in the expression of an unknown 
transcriptional repressor regulated by RpoS, which is able to repress ospA expression. 
Upon repression of ospA, OspA production is decreased and there is a reduction in the 
surface-associated OspA. This reduction further activates the Rrp2-RpoN-RpoS pathway 
to achieve and maintain the maximal level of Rrp2-RpoN-RpoS activation to encourage 
the expression of OspC leading to B. burgdorferi’s migration from the tick midgut to 
establish infection in mammals. 
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Figure 16. Proposed model for the positive feedback circuit between the activation 
of Rrp2-RpoN-RpoS regulatory pathway and the reduction of OspA. 
The activation of the Rrp2-RpoN-RpoS is hypothesized to be activated upon tick feeding 
by an unknown signal. The activation of this pathway results in expression of an 
unknown transcriptional repressor which is able to repress ospA. OspA production is 
decreased upon the repression of ospA causing a reduction in the surface-associated 
OspA. The reduction further activates the Rrp2-RpoN-RpoS pathway to achieve and 
maintain the maximal level of Rrp2-RpoN-RpoS activation, which in turn activates 
expression of ospC (←, positive activation; Ⱶ, negative activation). 
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The proposal of an in vitro model of ospA repression 
The expression of ospC is temperature-dependent during in vitro cultivation in BSK. 
Expression of OspA, however, is not temperature-dependent; OspA is abundantly 
expressed during in vitro cultivation at both 23°C and 37°C. Since OspA is not 
temperature-dependent like OspC, there has been a lack of an in vitro model for 
studying the regulation of ospA. Studying the downregulation of ospA can only be done 
in vivo, which is very difficult, therefore very little is known about the mechanism 
underlying the downregulation of ospA. 
 
While the complete mechanism of ospA downregulation has not been fully elucidated, 
Caimano et al. discovered that the alternative sigma factor RpoS is required for the 
repression of ospA (2005). RpoS likely represses ospA by either 1) binding directly to 
the ospAB promoter; or 2) by controlling the expression of an unknown ospA repressor. 
 
He and coworkers have shown that rpoS is constitutively activated in an ospAB mutant 
(He et al., 2008). Thus, the ospAB mutant can serve as a system to study the repression 
of the ospAB promoter in vitro. To develop this system, the pLuc-FL plasmid (a shuttle 
vector containing the luciferase reporter under the control of the full-length ospAB 
promoter) was electroporated into the ospAB mutant. In this construct, the ospAB mutant 
constitutively expresses rpoS and subsequently RpoS represses the full-length ospAB 
promoter (probably either directly or indirectly). The full-length ospAB promoter controls 
the expression of a luciferase reporter to measure the level of ospA repression by RpoS 
(Figure 17A).  
 
The pLuc-FL plasmid was transformed into both the wild-type parental BbAH130 and the 
ospAB mutant. These strains were grown in BSK at 37°C and analyzed by the luciferase 
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assay. The ospAB mutant had reduced luciferase activity compared to the wild-type 
BbAH130 (Figure 17B). The reduced luciferase activity in the ospAB mutant indicates 
that RpoS was able to repress the ospAB promoter. This ospAB mutant containing the 
luciferase reporter under the control of the ospAB promoter can be used as a tool to 
study the repression of ospA in vitro. This is a novel in vitro model of ospA repression. 
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Figure 17. Establishment of an in vitro model of ospA repression. 
(A) Schematic of proposed in vitro model of ospA repression. In ospAB mutant B. 
burgdorferi (ΔospAB), RpoS expression is constitutive. RpoS is required for the 
repression of ospA via an unknown mechanism: either RpoS directly represses ospA or 
RpoS influences the expression of an unknown ospA repressor. The luciferase reporter 
expressed by the full-length ospAB promoter within the ospAB mutant can used to 
measure the level of ospAB promoter repression due to the overexpression of the ospA 
repressor. (B) BbAH130 (wt) and the ospAB mutant (ΔospAB), both containing the 
shuttle vector with the full-length ospAB promoter controlling luciferase expression, were 
grown at 37°C. The constitutive flaB promoter and a promoterless promoter (none) 
controlling luciferase expression were used as controls.  
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Deletion of the T-Rich element results in increased luciferase expression using 
the in vitro model of ospA repression 
We hypothesize that in ospA repression conditions, RpoS controls an unknown 
repressor (or repressors) which bind to the ospAB promoter at one or more of the three 
putative cis-elements (Figure 16). To determine which of the three putative cis-
element(s) are required for the full repression of ospA, we employed the in vitro model of 
ospA repression where rpoS is constitutively expressed (Figure 17). Using this model, 
the ospAB mutant, which constitutively expresses the putative ospA repressor, was 
electroporated with a shuttle vector containing the luciferase reporter under the control of 
either 1) the full-length ospAB promoter, PospAB-FL; 2) the PospAB-∆IR promoter which 
is lacking the IR element; 3) the PospAB-∆IR,Rept promoter lacking the region 
encompassing the IR and Rept elements; or 4) the PospAB-∆IR,Rept,T-Rich promoter 
which lacks all three putative cis-elements. These strains were grown at 37°C in BSK 
medium and then harvested and prepared for the luciferase assay. The PospAB-
∆IR,Rept,T-Rich strain had a significant increase in luciferase expression compared to 
the full-length, PospAB-∆IR, and PospAB-∆IR,Rept promoters (Figure 18A). This data 
suggests that the T-Rich region is required for full repression of ospA and that RpoS 
either directly binds to the T-Rich region or RpoS controls a repressor which binds to the 
T-Rich region.  
 
To determine if the T-Rich region alone is responsible for the full repression of ospA, we 
used our full-length ospAB promoter with the mutated T-Rich region (PospAB-T-Rich-
mut) controlling luciferase expression and placed the construct in the ospAB mutant B. 
burgdorferi and grown in vitro at 37°C. The luciferase expression levels of the PospAB-
T-Rich-mut promoter was compared to the PospAB-FL. The PospAB-T-Rich-mut 
promoter had significantly increased levels of luciferase (Figure 18B). The reduced 
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ospA repression caused by the mutagenesis of the T-Rich region indicates that the T-
Rich region alone is responsible for the full repression of ospA. 
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Figure 18. Influence of cis-elements on luciferase repression using the in vitro 
model of ospA repression. 
(A) Luciferase assay of the ospA mutant transformed with a shuttle vector containing the 
luciferase reporter under the control of either constitutively expressed flaB promoter 
(PflaB), promoterless (none), the full-length ospAB promoter (PospAB-FL), the ospAB 
promoter lacking the IR region (ΔIR), the ospAB promoter lacking the IR and Repeats 
regions (ΔIR,Rept) and the ospAB promoter lacking all three putative cis-elements 
(ΔIR,Rept,T-Rich). Strains were grown in BSK at 37°C and prepared for luciferase 
assay. (B) The ospAB mutant strain electroporated with a shuttle vector containing the 
A 
B 
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luciferase reporter under the control of either the constitutively expressed flaB promoter 
(PflaB), the full-length ospAB promoter (PospAB-FL), and the PospAB-FL promoter with 
a mutated T-Rich region (PospAB-T-Rich-mut). Strains were grown in BSK at 37°C and 
prepared for luciferase assay (*, p<0.05 using paired Student’s t-test).
 
 
64 
Addition of norepinephrine results in a decrease of repression using the in vitro 
model of ospA repression 
During mammalian infection, ospA is continually repressed. However, when an infected 
mammal is bitten by a naïve tick, ospA must be expressed in order for the B. burgdorferi 
to attach to colonize the tick midgut through OspA. The mechanism by which ospA is 
able to switch from repression to expression within the mammalian environment is not 
clear, although it is speculated that catecholamines from the host are able to signal the 
release of the repression of ospA (Scheckelhoff et al., 2007). Catecholamines, such as 
norepinephrine and epinephrine, are released by the mammalian host upon the 
presence of a stressor- such as a tick bite. To determine if the catecholamine 
norepinephrine is able to release ospA repression, B. burgdorferi were grown in the in 
vitro model of ospA repression in BSK containing either BSK only or BSK with the 
addition of norepinephrine. The full-length ospAB promoter (PospAB-FL) and the ospAB 
promoter without any of the three putative cis-elements (PospAB-∆IR,Rept,T-Rich), both 
controlling the luciferase reporter, were cultivated.  
 
The addition of norepinephrine to the in vitro model of ospA repression resulted in an 
increase of ospA expression, indicating release of ospA repression in both the ospAB 
promoter containing all three putative ospA cis-elements (PospAB-FL) as well as the 
ospAB promoter lacking all three putative ospA cis-elements (PospAB-∆IR,Rept,T-Rich) 
(Figure 15). The release of repression in the promoter lacking all three putative cis-
elements suggests that norepinephrine releases the repression of ospA through a 
mechanism independent of any of the three putative cis-elements. 
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Figure 15. Effect of norepinephrine on luciferase expression driven by various 
ospAB promoters. Luciferase assay of the ospAB mutant B. burgdorferi strain 
(ΔospAB) transformed with the various pLuc shuttle vectors containing either the 
constitutively activated promoter (PflaB), promoterless (None), full-length ospAB 
promoter (PospAB-FL) or truncated ospAB promoter (PospAB-∆IR,Rept,T-Rich) were 
treated at 37°C with 10 µM norepinephrine (BSK+NE) or without norepinephrine (BSK 
Only) for 48 hours and harvested at late logarithmic phase (*, p < 0.05; **, p<.01 using 
ANOVA). 
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Section III. Host-adapted model for studying ospA repression 
 
B. burgdorferi cultivated in dialysis membrane chambers exhibits reciprocal 
regulation: repression of OspA and expression of OspC 
Studying the repression of ospA in the past has been difficult. During in vitro cultivation, 
ospA is constitutively expressed making the study of repression impossible; however, 
during in vivo conditions, ospA is constitutively repressed. The repression of ospA can 
be reproduced using the host-adapted spirochete model. The host-adapted spirochete 
model was developed by Akins et al. (1998) in order to obtain sufficient amounts of 
spirochetes from the vertebrate host environment for further assays and evaluations. In 
this method, B. burgdorferi is cultivated within DMC’s of 10 kDa pore size to retain the 
bacteria within the chamber. The chamber is surgically implanted into the peritoneal 
cavity of a rat and incubated for two weeks before harvesting the DMC’s to recover the 
Borrelia. Borrelia cultured in this manner display a similar antigenic composition to that 
of bacteria during mammalian infection. Specifically, ospA repression can be observed in 
B. burgdorferi cultured in this manner.  
 
To establish the host-adapted model, the wild-type infectious strain BbAH130 used in 
these studies was cultivated within DMC’s of Sprague-Dawley rats. The culture was 
incubated within the peritoneum for two weeks before harvest. OspA was expressed in 
the in vitro grown B. burgdorferi, as expected, because ospA is constitutively expressed 
in vitro. However, there was no OspA expressed in the host-adapted spirochete model 
culture (Figure 19). The repression of ospA within the host-adapted spirochete model 
shows that this model is an excellent tool that mimics the in vivo repression of ospA.  
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Figure 19. Establishment of the host-adapted model. 
BbAH130 (AH130) was either cultivated in BSK at 37°C (in vitro) or within DMC’s (10 
kDa pore size) inside the peritoneal cavity of a Sprague-Dawley rat for two weeks. 
Whole cell lysates were subjected to SDS-PAGE before Coomassie blue staining. 
Protein bands corresponding to OspA and OspC are indicated on right. Protein size is 
indicated on left in kilodaltons (kDa). 
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Deletion of the T-Rich element results in increased luciferase expression using 
the host-adapted model  
Using the in vitro model of ospA repression, it was determined that the T-Rich element 
was required for the full repression of ospA. To confirm the in vitro model of ospA 
repression, wild-type BbAH130 was electroporated with the shuttle vectors expressing 
the luciferase reporter under the control of either the full-length ospAB promoter or the 
PospAB-∆IR,Rept,T-Rich promoters. These constructs were cultivated in the host-
adapted model for two weeks and then harvested and prepared for luciferase assay. The 
PospAB-∆IR,Rept,T-Rich had a higher amount of luciferase activity than the full-length 
ospAB promoter (Figure 20). This suggests that the PospAB-∆IR,Rept,T-Rich promoter 
is lacking a cis-element essential for the repression of ospA within the host-adapted 
model. This result agrees with previous findings from the in vitro model of ospA 
repression.  
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Figure 20. Influence of host signals on luciferase expression of B. burgdorferi 
cultivated in the host-adapted model. 
Luciferase assay of the wild-type B. burgdorferi strain BbAH130 transformed with shuttle 
vectors expressing luciferase under the control of either the full length ospAB promoter 
(FL) or the ΔIR,Rept,T-Rich ospAB promoter. The constitutively expressed flaB promoter 
(PflaB) was used as a control (*, p<0.05 using paired Student’s t-test). 
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BB0219, a manganese transporter, is not essential for B. burgdorferi growth 
within the host-adapted model 
B. burgdorferi is transmitted to mammals through the Ixodes tick vector. Borrelia must 
adapt to the unique environments of its two hosts to be able to establish infection. To 
establish infection, the bacterium needs to acquire essential nutrients and transition 
metals, like iron and magnesium, from its hosts. A metal transporter, BmtA (BB0219) 
has been recently identified as being important for transporting manganese and 
detoxifying reactive oxygen species (Ouyang et al., 2008).  
 
A bmtA mutant was created by disrupting BB0219. The phenotype of the bmtA mutant 
displayed a decreased uptake in magnesium, an inability to establish an infection within 
mice and the need of bmtA for reactive oxygen species protection. We sought to 
determine if the bmtA mutant’s inability to establish an infection is due to a defect in the 
mutant’s growth. We cultivated the bmtA mutant within DMC’s implanted within the 
peritoneal cavity of a rat. Upon harvest, B. burgdorferi was enumerated and it was found 
that both the wild-type and the bmtA mutant had comparable growth within the DMC 
indicating that BmtA is not essential for growth within the host-adapted model (Table 3). 
Rather than BmtA affecting growth, BmtA must play a role in establishing infection in 
some other manner. 
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Table 3. Growth of wild-type, bmtA mutant and complement Borrelia within the 
DMC. 
 
Growth represented as “+”.  
  
Growth Condition WT bmtA mutant Complement
In vitro ++++ +++ ++++
Mice ++++ ++++
DMC ++++ ++++ ++++
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CHAPTER FOUR: DISCUSSION 
 
The T-Rich Region is required for the full activation of the ospAB promoter 
Previous studies on ospA regulation had used nonreplicating, transient reporters to 
measure the ospAB promoter efficacy. These studies failed to use reporters which are 
able to replicate in B. burgdorferi, due to their lack of a B. burgdorferi replication origin. 
Therefore these previous studies were not as accurate as would be if using a stable 
reporter construct. Unlike the previous studies, to ensure a more accurate measurement 
and evaluation of ospAB promoter activity, we 1) used shuttle vectors that could 
replicate within B. burgdorferi; and 2) used the luciferase reporter which is generally 100-
fold more sensitive than the previously used CAT reporter.  
 
In our studies, we the luciferase reporter which was codon-adapted to B. burgdorferi 
(Blevins et al., 2007). B. burgdorferi has a GC content of only 28.6%, so the luciferase 
gene was codon-adapted to ensure that the luciferase gene was accurately representing 
the transcriptional activity rather than having a codon bias (Fraser et al., 1997). To 
determine which of the three putative cis-elements was required for the full activation of 
ospA, the luciferase reporter was placed under control of the full-length ospAB promoter 
and its activity was compared to several truncated ospAB promoters which deleted 
various regions containing cis-elements. We had observed that the deletion of the 
ospAB promoter region spanning from the IR to the Repeat elements did not cause a 
significant decrease in ospAB promoter expression. However, when the ospAB promoter 
region spanning the IR, Rept and T-Rich regions was deleted, there was a significant 
decrease in ospAB promoter expression. This suggested that the T-Rich region was 
required for the full activation of ospA.  
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The same series of ospAB promoters used to control luciferase expression in a wild-type 
Borrelia strain were placed to control the native ospA reporter within an ospAB mutant 
strain to evaluate which putative cis-element was required for the full activation of ospA. 
The native ospA reporter demonstrated similar results to the luciferase reporter results: 
deletion of the IR and Rept region together did not cause a significant decrease in ospA, 
however, deletion of the IR, Rept, and T-Rich regions together resulted in a decrease in 
ospA. These ospA activation studies using a luciferase reporter and ospA reporter both 
suggested that the T-Rich region was required for the full activation of the ospAB 
promoter. However, we needed to ensure that the T-Rich region was solely responsible 
for the decrease in ospAB promoter activation, rather than the T-Rich region in 
conjunction with either the IR or Rept regions. To do this, site-directed mutagenesis was 
performed to mutate a 10 bp region of the T-Rich region of the full-length ospAB 
promoter to create PospAB-T-Rich-mut. Like the other promoters tested, the PospAB-T-
Rich-mut promoter was placed controlling luciferase expression and evaluated using the 
luciferase assay. The PospAB-T-Rich-mut promoter showed reduced luciferase 
expression compared to the full-length ospAB promoter indicating that the T-Rich region 
alone was responsible for the reduction in ospAB promoter activity observed in these 
studies. Our ospA expression findings were consistent with previous data in the literature 
demonstrating that the T-Rich region is required for the full activation of the ospAB 
promoter within a transient reporter system (Sohaskey et al., 1999). Our studies, which 
used stable reporters, showed that the T-Rich region is an important regulatory element 
required for the full activation of ospA.  
 
A Novel Approach to Studying ospA repression 
Studying ospA repression in Borrelia has proven to be a very difficult task as ospA is 
only expressed during in vivo cultivation and thus collecting enough bacterial sample 
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volume to do experiments has proven to be very laborious. Therefore, there is very little 
known about the repression of ospA other than that it is mediated by RpoS in an 
unknown manner (Caimano et al., 2005). To create an easier way to study ospA 
repression, we developed an in vitro model to study ospA repression. This was achieved 
by using the luciferase reporter under the control of the ospAB promoter within an ospAB 
mutant strain, which has RpoS constitutively expressed and thus mediating the 
repression of ospA. This advance in the field should make it easier for researchers to 
study ospA repression. 
 
The T-Rich Region is required for the full repression of the ospAB promoter 
Our in vitro model to study ospA repression was used to determine which cis-elements 
are required for the full repression of ospA. The luciferase reporter was placed under 
control of the full-length ospAB promoter and other truncated ospAB promoters so the 
cis-elements required for ospA repression could be determined. Deletion of the IR or IR 
Rept regions did not cause a significant change in ospAB promoter activity compared to 
the full-length ospAB promoter. However, deletion of the IR, Rept, and T-Rich regions 
resulted in an increase in promoter activity showing that the truncated promoter was not 
able to be fully repressed. This indicated that the T-Rich region was important for the full 
repression of ospA. To ensure that the decreased repression was due solely to the T-
Rich region and not the T-Rich region in conjunction with the IR or Rept regions, we 
compared the PospAB-T-Rich-mut promoter, which has the full-length ospAB promoter 
with a mutated T-Rich region, to the full-length ospAB promoter. Our results had shown 
a decrease in repression which indicates that it is solely the T-Rich region responsible 
for the decrease in ospA repression. Our in vitro model of ospA repression demonstrated 
that the T-Rich region of the ospAB promoter was required for the full repression of the 
ospAB promoter.  
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To further study ospA repression, we explored the effects of norepinephrine on ospA 
repression. A previous study demonstrated that norepinephrine is able to de-repress 
ospA (Scheckelhoff et al., 2007). De-repressing ospA is required for the tick to acquire 
Borrelia from an infected mammal. In an infected mouse, ospA is repressed, however, 
upon tick feeding, B. burgdorferi must de-repress ospA in order to colonize the tick gut 
where OspA binds specifically to the tick’s TROSPA receptor. The previous study 
demonstrates that when a tick bites the mammal, the host releases norepinephrine and 
this contributes to de-repressing ospA. Given this, we wanted to determine if 
norepinephrine would affect ospA repression in our in vitro repression model.  
 
Using our in vitro repression model, we cultured the ospAB mutant containing either the 
full-length ospAB promoter (PospAB-FL) or the ospAB promoter lacking the IR,Rept, and 
T-Rich region (PospAB-∆IR,Rept,T-Rich) in BSK media only or BSK media containing 
norepinephrine. For both the PospAB-FL and the PospAB-∆IR,Rept,T-Rich promoter, 
there was an increase in luciferase expression upon the addition of norepinephrine 
indicating that there was a de-repression of ospA for both promoters. From this study, 
we concluded that norepinephrine is able to de-repress ospA, which is agreement with 
the previous studies. Further advancing this, we were able to conclude that the de-
repression of ospA is independent of the T-Rich region. There is likely another regulatory 
element between the T-Rich region and the ospA gene that plays a role in the de-
repression of ospA via the addition of norepinephrine. 
 
One last approach we used to study the repression of ospA was the host-adapted 
animal model in which Borrelia are cultivated within DMC’s implanted into the peritoneal 
cavity of a rat (Akins et al., 1998). We first established the host-adapted model within our 
lab. We observed that growing wild-type Borrelia within the DMC’s resulted in the 
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repression of ospA. Since ospA was able to be repressed, we were able to use the host-
adapted model to confirm our ospA repression finding we observed in vitro. In the 
DMC’s, we grew the wild-type Borrelia strain with luciferase reporter expression under 
the control of either the full-length ospAB promoter or the PospAB-∆IR,Rept-T-Rich 
promoter. There was an increase in luciferase expression in the PospAB-∆IR,Rept-T-
Rich promoter compared to the full-length ospAB promoter which mirrors our results 
from the in vitro studies that the T-Rich region is required for the full repression of ospA. 
One caveat of the host-adapted model is that, unlike in vitro cultivation, there is no 
antibiotic selection in order for the plasmids to be retained and replicating within Borrelia. 
However, it is probable that since both strains used the same parental vector and are 
identical except at the region of the ospAB promoter, that the plasmid would be lost at 
the same rate for both strains.  
 
Previous studies in ospA repression had already shown that RpoS is required for the full 
repression of ospA. Our studies further dissected the mechanism of ospA repression by 
demonstrating that the T-Rich region of the ospAB promoter is an important cis-element 
required for the full repression of ospA. For ospA repression, Rrp2 becomes 
phosphorylated upon tick feeding. Then, Rrp2 in conjunction with RpoN activate RpoS. 
RpoS then represses ospA either by 1) associating with an in vivo-specific accessory 
factor that allows RpoS to directly bind to the T-Rich cis-element of the ospAB promoter; 
or 2) by controlling the expression of an unknown ospA repressor protein that binds to 
the T-Rich cis-element of the ospAB promoter to block RpoS-dependent transcription 
initiation. For ospA activation, on the other hand, RpoD is able to bind to the T-Rich 
region of the ospAB promoter to drive the transcription initiation of ospA. 
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CHAPTER FIVE: FUTURE DIRECTIONS 
 
Potential role of BosR as a repressor of ospA  
In B. burgdorferi, BosR (BB0647) has been found to encode a novel DNA-binding 
protein in the Fur/Per family of transcriptional regulators. BosR is required for the 
induction of RpoS (Hyde et al., 2010; Ouyang et al., 2009). RpoS represses ospA via an 
unidentified mechanism (Caimano et al., 2005). A recent study has discovered that 
BosR binds specifically to the rpoS gene at three distinct sites. By making specific 
mutations in the rpoS gene and measuring the binding capability of BosR, a novel direct 
repeat and inverted repeat sequence (TAAATTAAAT), which is critical for BosR binding, 
was identified (Ouyang et al., 2011). This direct repeat sequence which BosR 
specifically binds is similar to areas upstream of the T-Rich element found on the ospAB 
promoter. Since BosR regulates RpoS, and RpoS is required for the repression of ospA, 
it is plausible that BosR could play a key role in ospA repression through binding to a 
putative BosR binding site located on the ospAB promoter.  
 
In an rpoS mutant, ospA is not able to be repressed (Caimano et al., 2005). Thus if 
BosR directly represses ospA, then inducing BosR in an rpoS mutant should restore 
ospA repression. These experiments can be performed in two different ospA repression 
conditions: 1) in the host-adapted model, or 2) in the ospAB mutant. For the host-
adapted model study, either wild-type, rpoS mutant, or an rpoS mutant complemented 
with bosR can be electroporated with a shuttle vector containing the full-length ospAB 
promoter controlling luciferase expression. The wild-type Borrelia would display low 
luciferase expression because this condition supports the repression of ospA. The rpoS 
mutant would display high luciferase expression because previous studies have shown 
that ospA is not able to be repressed in rpoS mutants (Caimano et al., 2005). This is 
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likely due to the absence of a repressor controlled through RpoS. The rpoS mutant 
complemented with bosR would have low luciferase expression if BosR is able to 
specifically bind to the ospAB promoter to cause repression. If complementation with 
bosR results in high luciferase expression, this would indicate that BosR is not 
specifically binding to the ospAB promoter to cause repression and that repression of 
ospA is due to a trans-factor(s) controlled by RpoS. 
 
A second method of determining if BosR is able to directly repress ospA would be by 
using the in vitro model of ospA repression. In this method, the same shuttle vector 
which contains luciferase under the control of the full length ospAB promoter would be 
electroporated into either 1) the BbAH130 wild-type strain; 2) the ospAB mutant strain; 3) 
the ospAB, rpoS double mutant; or 4) the ospAB, rpoS double mutant complemented 
with bosR. The strains would be cultivated at 37°C and analyzed by luciferase assay. 
The wild-type strain would expect to have high luciferase activity because ospA is highly 
expressed during in vitro cultivation. The ospAB mutant would be expected to have no 
luciferase activity because this is the in vitro model of ospA repression where the 
abrogation of ospAB causes ospA repression conditions. The ospAB, rpoS double 
mutant would show high luciferase activity because RpoS is required for the repression 
of ospA. Lastly, the ospAB mutant strain complemented with bosR would exhibit no 
luciferase activity if BosR is able to bind to the cis-elements of the ospAB promoter to 
cause repression. However, if BosR is not able to specifically bind to the ospAB 
promoter to repress its activity, then the strain would show high levels of ospA because 
ospA cannot be repressed in the absence of RpoS. 
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Identification of putative trans-factors via a knowledge-based approach 
Previous studies have shown that B. burgdorferi rpoS mutants are not able to 
downregulate OspA even during in vivo cultivation when ospA is normally repressed. 
The precise mechanism by which RpoS controls ospA repression is not known. We 
hypothesized that an ospA repressor is regulated under the control of RpoS and that a 
knowledge-based approach can be used to help identify putative DNA-binding proteins 
controlled by RpoS.  
 
Microarray data from Caimano et al. (2005) and Boardman et al (2008) identified genes 
being differentially regulated by RpoS within the host-adapted model. From this 
microarray data, a list was compiled which identified genes that appeared to be the most 
highly regulated by RpoS. From this list of RpoS-regulated genes, the genes with the 
highest transcript fold-change were next evaluated for their probability of binding to DNA. 
Their amino acid sequence obtained from Entrez Gene (NCBI) was entered on an online 
server (www.netasa.org/dbs-pred) to predict the probability of the protein binding to 
DNA. After determining the DNA-binding probability, we narrowed down the list to the 
top five gene candidates based on their: 1) fold change in the transcript levels between 
the RpoS mutant and the wild-type as determined from the microarray data; and 2) DNA-
binding capability as predicted by the online server. The top five gene candidates are 1) 
BBL29; 2) BBD01; 3) BB0449; 4) BBJ01; and 5) BBJ02.  
 
These putative DNA-binding proteins were cloned into a shuttle vector that placed their 
expression under the control of a constitutive promoter. Next, the shuttle vectors were 
electroporated into a wild-type B. burgdorferi strain. These strains were grown in vitro at 
23°C, a condition in which ospA is expressed, to determine if the any of the five 
repressor candidates were able to repress ospA. If the gene is an ospA repressor, then 
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the overexpression of the gene in the WT strain would result in lower or no ospA. There 
was no difference in any of the five expressed genes indicating that genes did not have 
an effect on ospA repression and therefore are not ospA repressors.  
 
In the future, other genes can be selected using out knowledge-based approach to 
determine if they are able to repress ospA. If the overexpressed gene does appear to 
repress ospA when overexpressed, an EMSA would need to be done to determine if the 
protein of interest is able to act as a trans-factor and bind to the ospAB promoter. Lastly 
to confirm that the gene is indeed an ospA repressor, the gene would need to be 
knocked out in B. burgdorferi and grown within a DMC. If ospA is not able to be 
repressed in this condition, then the gene would prove to be needed to repress ospA.  
 
Mass spectrometry identification of the putative trans-factors acquired using 
biotinylated ospAB promoter oligonucleotide 
The T-Rich region of the ospAB promoter has been identified as an important regulatory 
cis-element in both the expression and repression of ospA. The ospAB promoter can be 
used to isolate the trans-factor(s) binding to the ospAB promoter cis-elements by 
employing sequence-specific DNA affinity chromatography. In a method adapted from 
(Babb et al.), chemically synthesized biotin-labeled complementary 
oligodeoxynucleotides that encompassed the full-length ospAB promoter were 
purchased (2006). The full-length ospAB promoter was used because it contains the T-
Rich region, which we found was crucial for the full activation of ospA, and thus the 
activator is likely binding to this region. Next, the biotin-conjugated 
oligodeoxynucleotides were affixed to streptavidin magnetic beads and protein extracts 
from either wild-type B. burgdorferi (for ospA expression conditions since wild-type has 
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high ospA expression) or ospAB mutant (for the ospA repression conditions since the 
ospAB mutant has constitutive expression of an unknown ospA repressor) cultures were 
added. The supernatant was removed and the beads coated with biotin-labeled ospAB 
promoter were gently washed. Next, the proteins bound to the cis-element 
oligonucleotide fragments were eluted from the magnetic beads and separated by SDS-
PAGE and visualized. Protein bands were extracted and analyzed by matrix-assisted 
laser desorption ionization-time of flight (mass spectrometry) performed by the 
Proteomics Core Facility at Indiana University School of Medicine (Indianapolis, IN). The 
proteins were identified as shown in Table 4.  
 
Of particular interest is gene BBJ02 (Table 4). This gene was identified in our 
knowledge-based approach as being a putative ospA repressor due to its regulation by 
RpoS and its DNA binding probability. BBJ02 was constitutively expressed in an ospA 
activation condition to determine if it was able to act as an ospA repressor; it did not.  
 
In the future, the isolation of the activator need to be redone. To improve these studies, 
the bacterial lysis and washing steps need to be optimized to ensure less non-specific 
binding. Also, the full-length ospAB promoter with the mutated T-Rich region (PospAB-T-
Rich-mut) should be used as a control because it contains the same elements as the 
full-length promoter except the T-Rich region. Since the activator is likely binding to the 
T-Rich region, the PospAB-T-Rich-mut should not have the activator present in the 
proteins eluded from the promoter whereas the PospAB-FL should have the activator 
present. 
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Table 4. Proteins identified by mass spectroscopy to bind to the ospAB promoter. 
The name of the protein or gene (protein/gene) on the left and its putative role in B. 
burgdorferi (comments). The number of peptides is noted (peptides) and its number of 
distinct sequence (# of distinct sequences). 
 
protein/gene Comments Peptides # of distinct sequences
ospA outersurface protein 33
bbk32 p35 antigen 72 23
ospC outersurface protein 157 21
BBK01 membrane protein 39 21
FlaB Flagellin 22 11
BBG01 lipoprotein 17 10
BBI06 pfs protein (phosphorylate superfamily)11 8
DbpA adhesion protein 24 8
BB0603 membrane associate protein p66 9 7
BB0323 lipoprotein 7 7
dbpB adhesion protein 17 7
BBM27 lipoprotein 10 6
Bol26 surface protein 8 6
BB0238 6 6
WI91-23 REV protein 9 5
ospB outersurface protein 8 5
BB0689 outersurface protein 6 5
BBI39 4 3
bb0337 phosphopyruvate hydratase 3 3
bb0476 translation elongation factor 2 2
bba66 surface antigen p35 2 2
BBJ02 2 2
bb0034 outermembrane protein P13 2 2
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